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Premature birth has risen steadily over the last decade resulting in an increased 
number of infants needing neonatal intensive care. The demand for neonatal intensive 
care has lead to many improvements in the delivery of such care with an increase in the 
survival of the smallest and most premature infants. However, most of these infants are 
being discharged from neonatal intensive care units (NICU) with severe extrauterine 
growth restriction (EUGR). 
Extremely low birth weight (ELBW) infants born at 23-27 weeks gestation and 
who have a weight of less than 1,000 grams are at the highest risk for EUGR because of 
their low birth weight and extreme prematurity. The need for prolonged mechanical 
ventilation and blood pressure support delays the ELBW infant from receiving needed 
amounts of early nutrition during the first few weeks of life. This lack of early nutrition 
leads to large and ongoing energy and protein deficits, which have been cited as the 
leading cause of EUGR in the ELBW infant. Despite current evidence that supports the 
administration of early aggressive nutrition in the ELBW infant to improve extrauterine 
growth, clinical practice remains largely unchanged.  
The Institute of Medicine (IOM) in its 2008 report states that the use of evidenced 
based clinical practice guidelines (CPG) has the potential to reduce undesirable practice 
variation thereby eliminating the use of ineffective interventions. Developing evidenced 
based CPGs utilizing a systematic, rigorous and transparent process will serve to 
standardize practice while improving clinical outcomes. Therefore, the purpose of this 
doctoral project is to provide an evidence based CPG on the nutritional management of 
the ELBW infant. The CPG includes evidence based recommendations that are centered 
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on promoting adequate extrauterine growth during the NICU stay in order to prevent 
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NUTRITIONAL MANAGEMENT OF THE EXTREMELY LOW  
BIRTHWEIGHT INFANT: AN EVIDENCE BASED  
CLINICAL PRACTICE GUIDELINE 
CHAPTER 1 
BACKGROUND, PROBLEM and PURPOSE 
Premature birth has risen steadily over the last decade resulting in an increased 
number of infants needing neonatal intensive care. The demand for neonatal intensive 
care has lead to many improvements in the delivery of such care with an increase in the 
survival of the smallest and most premature infants. However, most of these infants are 
being discharged from neonatal intensive care units (NICU) with severe extrauterine 
growth restriction (EUGR) putting them at risk for poor neurodevelopment and severe 
handicaps later in life (Hans, Phylipow, Long, Thureen & Georgieff, 2009; Kashyap, 
2007; Martin, et al., 2009; Stephens, et al., 2009; Vlaardingerbroek, van Goudoever & 
van den Akker, 2009). 
EUGR occurs when a premature infant’s growth falls below the 10th percentile of 
that for a normal fetus at the same gestational age (Clark, et al., 2003; Coverston & 
Schwartz, 2005; Yu, 2005). The infants at highest risk for developing EUGR are those 
classified as extremely low birth weight (ELBW). ELBW infants born at 23-27 weeks 
gestation and who have a weight of less than 1,000 grams are at high risk for EUGR 
because of their low birth weight and extreme prematurity.  
 The extreme prematurity of the ELBW infant’s organs and organ systems limits 
their ability for transition to extrauterine life. Many ELBW infants require prolonged 
mechanical ventilation due to their immature lungs, blood pressure support due to their 
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immature myocardium, and parenteral nutrition due to their immature gastrointestinal 
system (Gleason & Devaskar, 2012). The need for such support delays the ELBW infant 
from receiving needed amounts of early nutrition during the first few weeks of life 
resulting in poor growth (Stephens et al., 2009). 
 In utero, the ELBW infant would be receiving twice the amount of amino acids 
needed for protein accretion with the excess amount being oxidized for energy production 
(Adamkin, 2005). Glucose would be delivered at a rate that meets fetal energy 
expenditure and would be controlled by maternal glucose concentration (Clark et al., 
2003). Lipid uptake would be minimal and be done at a rate that meets the essential needs 
for neuron development (Hay, 2006) 
  In contrast, during the first weeks of extrauterine life amino acids are withheld or 
given in minimal amounts due to concern for the ELBW infant’s ability to catabolize 
early amino acids (Adamkin, 2005; Hay, 2006). Glucose is given as the sole source of 
energy resulting in concentrations that are too high for the ELBW infant, leading to 
hyperglycemia (Hay, 2006). Intralipids are held due to hyperglycemia and the risks of 
lung injury and kernicterus (Clark, et al., 2003).  
 Postnatal nutrition regimens utilizing glucose as the sole energy source and 
lacking adequate amounts of protein result in large protein and energy deficits in the 
ELBW infant. These deficits may reach up to 300kcal/kg and 12g/kg of protein within 
the first week of life leading to altered growth at the cellular and systemic level (Clark et 
al., 2003). The cumulative and ongoing deficits of energy and protein are cited as the 
leading cause of EUGR in the ELBW infant (Adamkin, 2005; Clark et al., 2003; 
Coverston & Schwartz, 2005; Ehrenkranz, 2007; Hay, 2006).  
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 Extensive research has been conducted to determine the best nutritional regimen 
for preventing EUGR in the ELBW infant. Data from randomized controlled trials (RCT) 
strongly suggests providing nutrition that mimics the intrauterine environment may 
improve energy intake and prevent protein loss, thereby improving growth in the ELBW 
infant (Ibrahim, Jerondi, Baier, Dhanireddy & Krouskop, 2004; Wilson, et al., 1997).  
Despite these data providing strong evidence for improving EUGR, clinical practice 
remains largely unchanged. 
Bloom et al. (2003) found a wide variation in postnatal weight gain among 51 
NICUs within a healthcare network leading them to conduct a quality improvement 
project. Upon further review of each NICU, it was noted that systems of care and 
standards of practice varied based on healthcare provider habit or history of the unit. 
Hans et al (2009) believe this type of practice is due to a lack of knowledge, systematic 
planning and practice implementation.  Whereas, Ehrenkranz (2007) & Martin et al. 
(2009) believe this type of practice is due to the lack of evidence based CPGs. Therefore, 
the purpose of this doctoral project is to provide an evidence based CPG on the 
nutritional management of the ELBW infant. 
The aim of this CPG is to guide clinical practice in the nutritional management of 
the ELBW infant from birth to hospital discharge.  The evidence based recommendations 
address fluid and electrolyte management, energy and mineral intake, glucose 
administration, early aggressive nutrition, enteral feedings, and nutritional assessment. 
These recommendations are centered on promoting adequate extrauterine growth of the 





REVIEW OF THE LITERATURE 
This chapter is presented in three parts.  Part I presents an overview of evidence 
based practice (EBP), Clinical practice guidelines (CPG) and CPG development, 
formulation of clinical questions, systematic reviews, and evidence grading.  Part II 
presents an overview of clinical situations that must be considered in the nutritional 
management of the ELBW infant. Part III provides evidence tables developed from a 
review of the literature detailing the supportive data for this doctoral project. 
       The review of the literature was completed using Pubmed, The Cochrane Database of 
Systematic Reviews, and Cumulative Index to Nursing and Allied Health Literature 
(CINAHL) electronic databases. The literature search was restricted to include articles in 
the English language but no restrictions were placed on publication date or type of 
research study.  Search terms included laboratory assessment, nutritional assessment, 
growth and growth assessment, premature infant, low birth weight infant, very low birth 











PART I: OVERVIEW 
EVIDENCE BASED PRACTICE 
In Crossing the Quality Chasm: A New Health System for the 21
st
 Century, the 
Institute of Medicine (IOM) (2001) points out that the U.S. healthcare system lacks 
sufficient design to promote quality care due to an abundance of research not being 
translated into practice within a timely manner. This report is credited with highlighting 
the need for EBP, which is a problem solving approach that integrates the best evidence 
from systematic research with clinical expertise and patient values to make clinical care 
decisions (Fineout-Overholt, Levin & Melnyk, 2004; Mateo & Kirchhoff, 2009; 
Newhouse, Dearholt, Poe, Pugh & White, 2007). Generally, EBP is considered a process 
that includes: asking a clinical question in the PICO format, utilizing systematic reviews 
to evaluate and summarize the evidence, translating the evidence into CPGs and 
evaluating the outcomes (Fineout-Overholt, et al., 2004) The aim of EBP is to decrease 
variation in clinical practice that utilizes the best evidence to improve clinical care 
processes and outcomes.  
CLINICAL PRACTICE GUIDELINES 
A CPG is a set of systematically developed statements designed to guide 
clinicians and patients in their decisions about the appropriate health care for specific 
clinical conditions (IOM, 2008). The recommendations included in a CPG should be 
linked to the scientific research that supports them which is identified through a rigorous 
process of systematic review and appraisal of the literature (Hargrove, Griffer & Lund, 
2008; Melnyk, 2004; Poolman, Verheyen, Kerkhoffs, Bhandari & Schunemann, 2009; 
Turner, Misso, Harris & Green, 2008).Moreover, CPGs developed utilizing the evidence 
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obtained from systematic reviews may serve as key resources to translate the evidence for 
clinical practice, thus decreasing ineffective variation in practice and improving clinical 
outcomes.  
CLINICAL PRACTICE GUIDELINE DEVELOPMENT PROCESS 
The purpose of a CPG is to give clinicians and patients statements regarding the 
best evidence for making clinical health care decisions. However, many CPGs are being 
developed by national agencies and special interest groups leading to a decentralized 
process for CPG development creating bias and inherent problems with the final product 
(Bondmass, 2009; Clutter, 2009). In 2008, the IOM published Knowing What Works in 
Health Care: A Roadmap for the Nation, which called attention to the lack of 
standardization in the process for developing a CPG.  
In 2008, the IOM recommended that clinical recommendations in CPGs be 
developed by a panel of experts who are knowledgeable of the clinical problem and are 
capable of understanding the relevant research in order to make a sound judgment. The 
process should also include two separate grading systems; one to grade the quality of 
evidence and one to grade the strength of evidence. Furthermore, the IOM (2008) pointed 
out that using a standardized transparent and scientifically rigorous process would result 
in trusted CPGs that would discourage undesirable practice variation while encouraging 
the use of interventions that are known to be effective. 
CLINICAL QUESTION 
The first step in developing a CPG is asking a clinical question, which needs to be 
as specific as possible, since it will drive the strategies used to search the evidence 
(Newhouse et al., 2007). The PICO format is most commonly used to narrow the clinical 
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question and clearly identify the problem and key words that may be used for searching 
the evidence. PICO stands for P patient I intervention C comparison with another 
intervention and O outcomes. Asking clinical questions in this format allows one to 
conduct a comprehensive literature review in a systematic way to identify clinical 
research studies that truly answer the question. 
SYSTEMATIC REVIEW 
Systematic reviews are a summary of the research evidence in evaluating clinical 
interventions intended to treat and/or prevent disease (Stevens, 2008). The systematic 
review process includes retrieving, critically appraising and synthesizing randomized 
controlled trials to answer a clinical question (Melnyk, 2004). According to the IOM 
(2008) conducting systematic reviews delineates what is known and not known about the 
effectiveness of a health intervention. Systematic reviews are considered to be the 
strongest level of evidence, which should be used when making clinical decisions.  
GRADE SYSTEM 
 The GRADE (Grades of Recommendation, Assessment, Development and 
Evaluation) System provides a comprehensive, precise and transparent method for 
grading the quality of evidence and the strength of recommendations included in CPGs 
(Brozek et al., 2009; Guyatt, 2011). GRADE categorizes evidence as high, moderate, low 
and very low depending on a study’s methodology, consistency, precision and directness. 
The strength of a recommendation is categorized as strong or weak depending on the 
desirable effects of the intervention.  
 The GRADE system provides a simple and transparent but rigorous approach to 
grading the quality of evidence and the strength of recommendations when developing 
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CPGs. The use of  such a simplistic and transparent system to develop CPGs not only 
meets the IOM’s recommendations but the use of GRADE makes it easier for patients 
and their healthcare providers to interpret recommendations in a CPG when making 






















Part II: THE EXTREMELY LOW BIRTHWEIGHT INFANT 
The ELBW infant is usually born during the last part of the second trimester or 
the early part of the third trimester (23-27 weeks gestation). The second and third 
trimesters of pregnancy are characterized as a time in gestation when increased growth 
and development of the fetus is occurring (Gleason & Devaskar, 2012). An infant born 
during this time in gestation has underdeveloped organs and organ systems. The 
immaturity of the ELBW infant and the limited ability of their organ systems to regulate 
body function pose unique clinical situations that must be considered when caring for 
such infants (Lee & Jain, 2000). 
Fluid & Electrolyte Balance 
 The ELBW infant has a large amount of total body water due to a lack of fat 
tissue and a larger amount of lean body mass. At 24 weeks gestation, the fetus is 
estimated to have a total body water content of 90%, which is mostly contained in the 
extracellular space (Fusch & Jochum, 2005). This amount of fluid in the extracellular 
space results in a larger fluid load for the ELBW infant’s immature kidneys to excrete 
during postnatal diuresis.  
 Postnatal diuresis occurs in three phases: the pre-diuretic phase, diuretic phase, 
and post-diuretic phase. The pre-diuretic phase occurs during the first 24-48 hours of life 
and is characterized by low urine output due to a fall in glomerular filtration rates (GFR) 
(Lee & Jain, 2000). Oliguria during the pre-diuretic phase is usually prolonged in the 
ELBW infant due to a lower fractional excretion of sodium (FENa) and the presence of 
respiratory distress (Fusch & Jochum, 2005). As respiratory distress resolves and FENa 
improves urine output starts to increase and is followed by the diuretic phase, which may 
10 
 
last 2-4 days. The diuretic phase is marked by high urine output and insensible water loss 
due to extracellular fluid volume contraction (Lee & Jain, 2000). During the diuretic 
phase, the ELBW infant is at high risk for fluid and electrolyte imbalances due to the 
large amount of insensible water loss (IWL) via the immature epidermal skin layer , 
which is estimated to be as high as 5-7ml/kg/day (Baumgart, 2008; Fusch & Jochum, 
2005).  
 Fluid and electrolyte balance during the diuretic phase of postnatal diuresis is 
critical in the ELBW infant. Failure to replace IWL will result in dehydration and 
hypernatremia whereas failure to administer adequate sodium at a time of high FENa 
results in hyponatremia (Bhatia, 2006). Potassium balance is also affected by the amount 
of IWL and the ELBW infant may experience non-oliguric hyperkalemia that occurs 
when intracellular potassium shifts out of the cell due to the contraction of the 
extracellular fluid compartment (Baumgart, 2008). The increased level of extracellular 
potassium coupled with the ELBW infant’s diminished capability of excreting potassium 
during the diuretic phase of postnatal diuresis leads to further elevation of potassium 
levels and the possibility of cardiac arrhythmias (Lee & Jain, 2000). 
 The post diuretic phase of postnatal diuresis usually occurs within 1-2 weeks of 
life when urine output normalizes and the infant reaches a steady state of fluid balance 
(Fusch & Jochum, 2005). This phase marks the completion of extracellular fluid volume 
contraction, a decrease in total body water, and an increase in cell mass (Lee & Jain, 
2000). Postnatal diuresis results in a large amount of fluid loss and postnatal weight loss 
for the ELBW infant. Although weight loss is expected during postnatal diuresis the 
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ELBW infant loses 5-10% more of their birth weight than preterm infants born at higher 
gestational ages (Fusch & Jochum, 2005). 
Energy Requirements 
 The ELBW infant has a large body surface area relative to body mass and is 
poorly insulated due to their thin skin and lack of subcutaneous fat stores leading to rapid 
heat loss and the need for increased energy to maintain a normal body temperature (Lee 
& Jain, 2000). IWL during postnatal diuresis further increases the energy needed for the 
ELBW infant to maintain their own temperature (Hay, 1994). Although placing ELBW 
infants in heated and humidified double walled isolettes improves thermoregulation their 
energy requirements to promote growth an adequate weight are higher than the average 
growing premature infant (Carr, Denne & Leitch, 2000). 
Glucose Management 
 Glucose is the predominant source of energy provided to the ELBW infant 
postnatally.  In-utero, glucose is delivered via the placenta at a rate that meets fetal 
energy needs and is dependent on maternal glucose concentrations with glycogen stores 
increasing throughout gestation (Clark et al., 2003). Birth of the ELBW infant results in 
minimal to no glycogen stores and poor glucose synthesis due to immature enzymes 
responsible for gluconeogenesis (Thureen & Hay, 2008). Decreased glycogen stores and 
inadequate glucose synthesis place the ELBW infant at high risk for hypoglycemia 
especially when faced with the stress from hypothermia, respiratory distress, and possible 
sepsis (Lee & Jain, 2000). 
  The ELBW infant’s risk of hypoglycemia and high energy needs leads the 
clinician to administer high rates of glucose. The inability of the ELBW infant to regulate 
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insulin production and glucose synthesis due to stress results in glucose intolerance and 
hyperglycemia (Hay, 1994). Hyperglycemia in the ELBW infant leads to a hyperosmolar 
state, osmotic diuresis and further fluid and electrolyte imbalances (Lee & Jain, 2000). 
Respiratory Complications 
 Managing early fluid and electrolyte imbalances in the ELBW infant can be quite 
difficult especially when the treatment for respiratory distress syndrome (RDS) and 
patent ductus arteriosus (PDA) involves restricting fluid intake for a period of time 
(Baumgart, 2008). RDS is a lung disease seen only in premature infants due to a lack of 
surfactant production. Surfactant is a phospholipid produced by type II pneumocytes, 
which are first seen at 24 weeks gestation and mark the beginning of saccular 
development of the lungs (Jobe, 2008) The saccular phase of lung development is when 
gas exchange begins to occur and defines the viability of an ELBW infant (Rutter & Post, 
2008).The lack of surfactant in the ELBW infant adversely affects pulmonary function 
due to an increase in atelectasis, poor pulmonary compliance and necrosis of epithelial 
tissue in the lungs (Lee & Jain, 2000). Synthetic surfactant does exist and rapidly 
improves pulmonary function once it is given. But, positive pressure and mechanical 
ventilation are still needed to support the ELBW infant. 
 Prolonged mechanical ventilation with positive pressure results in remodeling of 
the ELBW infant’s lung tissue (Rutter & Post, 2008). Positive pressure destroys epithelial 
tissue in the lung causing pulmonary edema from leakage of protein and extravascular 
fluid into the terminal conducting airways (Lee & Jain, 2000). Continued exposure to 
positive pressure ventilation promotes further destruction to lung tissue resulting in 
chronic lung changes and the development of bronchopulmonary dysplasia (BPD). 
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 BPD is the need for oxygen at 36 weeks postconceptual age (PCA) along with 
chest x-ray findings of pulmonary fibrosis and emphysematous changes (Walsh, 2008). 
The cause of BPD is multi-factorial and is the result of immature lungs damaged by 
mechanical ventilation and oxygen toxicity resulting in inflammation and cellular injury 
from oxygen radicals (Belik, 2008; Oh et al., 2005). Inflammation and cellular injury 
increase the need for ventilation causing a continual cycle of inflammation, cellular 
injury and pulmonary edema.  
 Developing BPD can be prevented if appropriate management strategies of RDS 
are utilized within the first few weeks of life. Treatment of RDS focuses on surfactant 
administration to decrease alveolar surface tension and improve pulmonary compliance 
(Jobe, 2008). The use of fluid restriction is meant to prevent pulmonary edema thereby 
reducing the need for high amounts of positive pressure and prolonged mechanical 
ventilation that lead to the development of BPD (Oh et al., 2005).  
Cardiovascular Complications  
 The development of BPD may also be influenced by the presence of a PDA 
within the first few weeks of life (Stephens et al., 2008). A PDA occurs when the fetal 
shunt called the ductus arteriosus (DA) fails to close after birth. In utero, blood enters the 
pulmonary artery from the left ventricle but is shunted through the DA due to high 
resistance in the pulmonary vasculature (Lee & Jain, 2000). After birth, the pulmonary 
vasculature decreases significantly in response to a high oxygen environment leading to 
closure of the DA (Gleason & Devaskar, 2012). The ELBW infant is born with RDS and 
lacks sufficient intra-arterial oxygen concentrations and arterial musculature to close the 
DA resulting in a PDA (Baumgart, 2008). 
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 A PDA allows oxygenated blood from the aorta to shunt across the DA into the 
lungs resulting in pulmonary edema. The shunting of blood across the DA results in 
hypotension and decreased systemic perfusion. A PDA left untreated may result in 
congestive heart failure and decreased kidney perfusion resulting in low urine output 
(Baumgart, 2008).   
 The treatment of a PDA is aimed at closing the DA. Medications can be given that 
work to decrease prostaglandin synthesis thought to be a contributor in the persistence of 
a PDA after birth. However, initial fluid restriction during the first few days of life is 
recommended to prevent fluid volume overload that may occur before postnatal diuresis 
takes place (Stephens et al., 2008). 
Gastrointestinal Complications 
 Fluid volume overload during the first week of life has been associated with an 
increased risk for necrotizing enterocolitis (NEC) (Bell & Accargeui, 2010). NEC is a 
disease more commonly seen in premature infants and its incidence increases as 
gestational age decreases (Neu, 2008). The exact pathogenesis of NEC is currently 
unknown. But certain factors are known to be associated with its development, which 
includes: an immature gastrointestinal system with a decreased barrier function, presence 
of an infectious organism, commencement of enteral feedings that provide a substrate for 
infection, and a possible ischemic or thromboembolic event (Lee & Jain, 2000; Neu, 
2008). 
 The clinical manifestations of NEC are characterized by abdominal distension and 
tenderness, feeding intolerance with large feeding residuals, bloody stools, bowel 
perforation, and intestinal necrosis. The diagnosis of NEC is done with abdominal x-ray 
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where pneumatosis intestinalis, or gas in the bowel wall, is seen (Neu, 2008). Treatment 
of NEC involves antibiotic therapy, gastric decompression, and in the most severe cases 
surgical resection of the necrotic bowel with ilieostomy.  
The severity of NEC and its associated morbidity and mortality have resulted in 
care providers withholding enteral feedings during the first few weeks of life in the 
ELBW infant (Adamkin, 2005). Withholding feedings to prevent NEC for long periods of 
time has been known to cause intestinal atrophy and further delay the development of the 
ELBW infant’s gastrointestinal system (Neu, 2008).  Prolonged periods of NPO status 
require the ELBW infant to receive total parenteral nutrition (TPN) for weeks and even 
months at a time placing them at risk for poor growth and nutritional deficiencies. 
Metabolic Complications 
One of the most common nutritional deficiencies seen in the ELBW infant is 
osteopenia of prematurity. Osteopenia of prematurity is a metabolic bone disease due to 
poor bone mineralization in the premature infant (Greer, 2008). The disease is 
characterized by calcium, phosphorus and vitamin D deficiencies. The disruption in 
mineral supply that occurs upon birth results in a bone remodeling process that increases 
bone resorption thereby decreasing bone density in the ELBW infant (Rigo, Pieltain, 
Salle & Senterre, 2007). Failure to provide adequate calcium, phosphorus and vitamin D 
exacerbates bone resorption leading to bone mineral content changes and possible 
fractures. 
Neurodevelopment 
Failure to provide adequate nutritional support in the ELBW infant not only 
results in poor bone mineralization but it decreases extrauterine growth resulting in poor 
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neurodevelopmental outcomes. Ehrenkranz et al. (2006) found that when extrauterine 
growth was increased from 12 to 21 grams/kg/day the incidence of cerebral palsy, 
abnormal neurologic examination and impaired neurodevelopment fell significantly. 
Stephens et al. (2009) found that the early administration of energy and protein in ELBW 
infants improved their neurodevelopmental outcomes. An increase of 10kcal/kg/day 
improved performance on the mental development index (MDI) by 4.6 points and for 
every gram/kg increase in protein intake MDI scores improved by 8.6 points (Stephens, 
et al., 2009).  
Neurodevelopment is perhaps the most important outcome for the ELBW infant 
since they are born with an immature brain and nervous system. Intraventricular 
hemorrhage (IVH)  is common in the ELBW infant due to their inability to regulate 
cerebral blood flow resulting in the rupture of blood vessels located in the germinal 
matrix, which is a highly vascularized area of the brain that regresses in size as gestation 
progresses and fully involutes at 34-36 weeks (Lee & Jain, 2000). In addition, 
malnutrition during a time of early brain development leads to the overall decrease in 




PART III: EVIDENCE TABLES 
Fluid & Electrolyte Management 
PICO Question: What type of fluid and electrolyte regimen meets the fluid and 
electrolyte needs of the ELBW infant? 
Search terms: fluid intake, water intake, electrolyte requirement, sodium intake, 
potassium intake, fluid and electrolyte management, premature infant, low birth weight 
infant, very low birth weight infant, and extremely low birth weight infant 
Summary of findings:  
A systematic review of premature infants and two observational studies in ELBW 
infants supported fluid restriction to prevent PDA, NEC, and BPD. Two RCTs were done 
in ELBW infants and found sodium restriction during the first few days of life promotes 
postnatal diuresis. An observational study in ELBW infants found that potassium should 
also be held in the first few days of life due to the risk of non-oliguric hyperkalemia. 
However, no studies were found that addressed daily maintenance requirements for 
sodium or potassium supplementation so, recommendations from the 2004 American 
Academy of Pediatrics (AAP) Committee on Nutrition were used. 
Insensible Water Loss 
PICO Question: Does humidification improve fluid and electrolyte management of the 
ELBW infant? 
Search Terms: insensible water loss, fluid and electrolyte management, premature infant, 





Summary of findings: 
 Clinical trials to determine the use of humidity to improve fluid and electrolyte 
balance in the ELBW are lacking. Two retrospective chart reviews were done after 
humidified isolettes were implemented in two different NICUs with similar findings of 






















Table 1: Fluid & Electrolyte Management 
 
Author/Year Study Design 
Level of Evidence 
Study Purpose/Study Sample 
Study Intervention/Study Outcome 
Results GRADE Quality 
of Evidence 
Fluid Management 











I Purpose: To investigate the effect of 
water intake on postnatal weight loss. 
The risks of dehydration, PDA, NEC, 
BPD, IVH and death in premature 
infants. 
 
Sample: 5 RCTs including preterm 
infants born at less than 37 weeks 
gestation. 
 
Intervention: Varying intakes of water 
given intravenously. 
 
Primary Outcomes: postnatal weight 
loss, dehydration 
 
Secondary Outcomes: PDA, NEC, 
BPD, oxygen requirement at 28 days of 
life and 36 weeks PCA, IVH, and death 
before discharge. 
Fluid restriction resulted in a 
higher postnatal weight loss. 
 
The risk of PDA, NEC, and 
death was significantly lower 
with fluid restriction.  
 
Water intake had no significant 
effect on BPD or IVH in 
premature infants.  
 
Fluid restriction had a non-







Oh et al., 2005 Retrospective 
Review of RCT 
IV Purpose: To determine the association 
between fluid intake and postnatal 
weight loss on the development of BPD 
among ELBW infants. 
 
Sample: 1,382 ELBW infants born 
from October 1999-August 2001 
included in the Neonatal Research 
Network Study on Glutamine 
Supplementation. 
 
Intervention: Varying fluid and 
sodium intake determined by the 
attending neonatologist. 
 
Outcomes: weight loss, BPD, and 
death 
Higher fluid intake given during 
the 2nd to 10th day of life was 
associated with the development 
of BPD. Infants given a higher 
amount of fluid had less weight 
loss and a significantly higher 










IV Purpose: To determine the effect of 
fluid intake on PDA, BPD and caloric 
intake in the ELBW infant. 
 
Sample: 204 infants born at less than 
32 weeks gestation and less than 1,250 
grams. 
Intervention: Infants were  
divided into 3 groups based on the 
amount of fluid intake prescribed by 
the attending neonatologist 
 
Outcomes: PDA, BPD, and caloric 
intake  
Infants who required the highest 
fluid intake were of lower 
gestational age and birth weight 
and had increased rates of PDA. 
The amount of fluids given 
during the first 3 days of life 
and during the first week of life 
was significantly associated 
with higher rates of BPD and 
PDA. Fluid intake 
(>170ml/kg/d) administered in 
the first few days of life is 
significantly associated with 
higher PDA rates. No difference 






Insensible Water Loss 
Gaylord, Wright, 




IV Purpose: To compare fluid and 
electrolyte management in ELBW 
infants nursed in humidified versus 
non-humidified isolettes. 
 
Sample: 155 ELBW infants admitted 
the NICU over a 4 year period. 
 
Intervention: care provided in a 
humidified versus a non-humidified 
isolette. 
 
Primary Outcomes: total daily fluid 
requirement, weight, urine output, 






Infants who were not cared for 
in humidified isolettes had 
higher fluid intake, less hourly 
urine output and more likely to 
have hypernatremia, 
hyperkalemia, and azotemia. 
 
No difference in the incidence 
of BPD or PDA between the 
groups. 
 
A higher number of gram 
negative isolates were found in 















IV Purpose: To identify changes in 
temperature, fluid and electrolyte 
management, growth and short term 
outcomes in ELBW infants nurse in 
humidified hybrid incubators compared 
to a cohort of patients cared for in a 
non-humidified incubator. 
 
Sample: 182 ELBW infants admitted 
to the NICU over a 3 year period. 
 
Intervention: care provided in a hybrid 
humidified isolette versus non-
humidified isolette. 
 
Primary Outcomes: temperature 
control, fluid intake, electrolyte 
balance, growth velocity. 
 
Secondary Outcomes: mortality, PDA, 
BPD, NEC, IVH and sepsis. 
Infants who received care in the 
hybrid humidified isolette had 
less fluid intake, urine output, 
insensible water loss, weight 
loss, and hypernatremia during 
the first week of life. 
 
Infants in the hybrid humidified 
isolette had less lab draws for 
electrolytes and less blood 
transfusions. 
 
Infants in the hybrid humidified 
isolettes had a higher incidence 
of hyponatremia on postnatal 
day 1 and higher growth 
velocity. 
 
Benefits were of the humidified 
hybrid isolette were more 
pronounced in infants with 
weight less than 750 grams. 
 
No difference in sepsis, NEC, 
IVH, or BPD, but infants who 
received care in a non-
humidified isolette had an 
increased incidence of severe 











Corcoran, Polin & 
Baumgart, 1992 
RCT II Purpose: To compare a salt restricted 
parenteral fluid regimen to a salt 
supplemented regimen. 
 
Sample: 17 infants born at less than or 
equal to 28 week gestation with a birth 
weight less than 1,000 grams 
 
Intervention: Sodium supplementation 
with 3-4meq/kg/day given for 5 days 
(treatment) versus no sodium given for 
5 days (control). 
 
Outcomes: sodium intake, fluid intake, 
urine output, FENa, and GFR. 
Sodium supplementation 
resulted in sodium balance of 
zero during the first 5 days of 
life.  
 
Sodium restricted infants had 
high rates of sodium excretion 
promoting a negative sodium 
balance. 
 
Increased fluid intake was noted 
in infants supplemented with 
sodium. 
 
Infants who were sodium 
restricted were more likely to 
have a normal serum osmolality 
and a decreased incidence of 
BPD. 
 
Both groups had neither dilute 
nor concentrated urine and had a 
















































































Purpose: To assess extracellular fluid 
volume regulation in very low birth 
weight infants. 
 
Sample: 20 infants with a birth weight 
between 700 and 1,500 grams. 
 
Intervention: 3meq/kg/day of sodium 
versus 1meq/kg/day given 
intravenously or by mouth. 
 
Outcomes: sodium intake, sodium 














Serum sodium levels increased 
significantly in both groups. 
Body weight decreased in both 
groups during the first 5 days of 
life.  
 
ECFV* decreased in both 
groups during the first 10 days 
of life and stabilized. Sodium 
balance was negative in both 
groups but became positive by 
10 days of age. Sodium 
excretion was higher in the 
3meg/kg/day group during the 
first 10 days of life; after days 
20 and 30 with no difference.  
 
Urine sodium and FENa 
increased in the 3meq/kg/day 
group between days 1 and 5 of 
life whereas urine sodium and 
FENa decreased in the 
1meq/kg/day group. 
Hyponatremia occurred more 






























& Markarian, 1997 
Observational 
Cohort 
IV Purpose: To characterize potassium 
metabolism during the three phases of 
fluid and electrolyte homeostasis. 
Sample: 31 infants with birth weight 
less than 1,000 grams 
 
Intervention: Use of potassium plasma 
concentration, potassium intake and 
output, and renal clearances to 
determine potassium metabolism 
 
Primary Outcomes: serum potassium 
values. 
Potassium values increased 
initially after birth despite 
potassium supplementation. 
 
Serum potassium levels peaked 
upon postnatal diuresis and 
decreased significantly once 
postnatal diuresis was complete. 
 
Infants who developed 
hyperkalemia were noted to 
have higher serum potassium 
levels within 12 hours of birth. 
 
 
Potassium excretion decreased 
after postnatal diuresis despite 












































PICO Question: What intake of calcium, phosphorus, and magnesium is required to meet 
the needs of the ELBW infant and promote bone mineralization? 
Search Terms: calcium intake, phosphorus intake, magnesium intake, mineral intake, 
bone mineralization, osteopenia of prematurity, premature infant, low birth weight infant, 
very low birth weight infant and extremely low birth weight infant. 
Summary of findings: 
 The recommended intake of calcium, phosphorus and magnesium has been 
estimated based on intrauterine accretion rates (AAP Committee on Nutrition, 2004). One 
RCT in infants less than 1,200 grams investigated using higher intakes of calcium and 
phosphorus in parenteral nutrition to improve mineral retention and bone mineral content 
and found administering higher rates of calcium and phosphorus in TPN improved early 
and long term bone mineralization. 
Table 2: Mineral Requirements 
 
       Note. BMC=bone mineral content 
 
Author/Year Study Design 
Level of Evidence 
Study Purpose/Study Sample 





Shulman, Burns & 
Laine, 1993 
RCT I Purpose: To determine the 
accumulative effects of increasing the 
quantities of calcium and phosphorus 
in TPN. 
 
Sample: 24 infants with birth weight 
less than 1,200 grams expected to 
have parenteral nutrition for at least 3 
weeks. 
 
Intervention: Standard concentration 
of calcium (1.25mmol) and 
phosphorus (1.5mmol) in parenteral 
nutrition versus High concentration of 
calcium (1.7mmol) and phosphorus 
(2mmol) in parenteral nutrition. 
 
Outcomes: retention of calcium and 
phosphorus and BMC*. 
Improved calcium and phosphorus 
retention was significantly higher in 
the HIGH group. 
 
Serum calcium, magnesium, 
parathyroid hormone, 25-
hydroxyvitamin D, and osteocalcin 
were similar in both groups. 
Serum phosphorus levels were 
significantly higher in the HIGH 
group. 
 
BMC* and the rates of increase in 
BMC* were improved between 
weeks 1 and 4, 1 and 8, and 1 and 
26 weeks PCA* in the HIGH. 
 










PICO Question: How many calories are needed to meet the energy expenditure of the 
ELBW infant?  
Search Terms: energy intake, caloric intake, energy expenditure, energy balance, 
premature infant, low birth weight infant, very low birth weight infant, and extremely low 
birth weight infant 
Summary of Findings: 
 Evidence is lacking to determine the energy requirements for the ELBW infant 
with most of the studies being conducted in healthy growing premature infants. One 
observational study compared energy expenditure in a group of ELBW infants to a group 
of critically ill term infants and found that energy expenditure in the ELBW was much 
higher than current estimates. A RCT investigated energy intake along with varying 
amounts of protein intake and found that a higher caloric intake of greater than 
70kcal/kg/day given with 2.7-3.5g/kg/day of protein leads to improved nitrogen retention 
and increased weight gain. Expert opinion recommends providing enough caloric intake 
to mimic intrauterine growth rates with energy requirements estimated utilizing the 









Table 3: Energy Requirements 










Author/Year Study Design 
Level of Evidence 
Study Purpose/Study Sample 








IV Purpose: To compare total daily 
energy expenditures and energy 
intakes in extremely premature 
infants to critically ill and healthy 
term infants. 
 
Sample: 10 ELBW infants less than 
28 weeks gestation. 
 
Intervention: Measurement of total 
energy expenditure and total body 
water using a double labeled water 
method in ELBW and term infants 
given varying caloric intake. 
 
Primary Outcomes: total energy 
expenditure, total body water, energy 
intake. 
Total energy expenditure was 
higher in the extremely premature 






were in abstract 
form only. 
Zlotkin, Bryan & 
Anderson, 1981 
 
RCT II Purpose: To evaluate the individual 
and combined effects of energy and 
nitrogen intake on nitrogen retention 
and growth. 
 
Sample: 22 appropriate for 
gestational age premature infants 
greater than 4 days of age. 
 
Intervention:  
Group 1: 50kcal/kg/d + 80mg/kg/d 
N* 
Group 2: 50kcal/kg/d + 640mg/kg/d 
N* 
Group 3: 80kcal/kg/d + 320mg/kg/d 
N* Group 4: 80kcal/kg/d + 
480mg/kg/d N*Group 5: 80kcal/kg/d 
+ 640mg/kg/d N* 
 
Group 1 & 2 received glucose as sole 
energy source. Group 3-5 were 
randomly assigned and received 
energy as glucose plus IL*. 
 
Outcomes: N* balance and weight 
gain. 
Increased non-protein energy 
resulted in improved nitrogen 
retention and weight gain. 
Increasing nitrogen intake while 
leaving energy intake constant had 
no effect on nitrogen retention. 
Increasing energy intake along 
with nitrogen intake correlated 
significantly with improved 
nitrogen retention. Providing 
energy intake of greater than 
70kcal/kg/day and 2.7-3.5g of 
protein/kg/d resulted in 













PICO Question: What glucose infusion rate meets the needs of the ELBW infant? Should 
hyperglycemia in the ELBW infant be treated with glucose restriction or insulin infusion? 
Search Terms: glucose infusion rate, glucose infusion, intravenous glucose, 
hyperglycemia, premature infant, low birth weight infant, very low birth weight infant, 
and extremely low birth weight infant 
Summary of findings: 
 Clinical trials are lacking to determine the appropriate glucose infusion rate for 
the ELBW infant so, experts suggest utilizing intrauterine glucose infusion rates as a 
guide for administering glucose to the ELBW infant (AAP Committee on Nutrition, 
2004; Hay, 2005).  Two systematic reviews were found, one that addresses the prevention 
of hyperglycemia and one that addresses the treatment of hyperglycemia. Findings in 
these systematic reviews confirm the lack of evidence in determining the appropriate 
glucose infusion rate for administering glucose and in treating hyperglycemia in the 
ELBW infant. The use of insulin to prevent hyperglycemia is not recommended due the 












Table 4: Glucose Management 
     Note. CLD=chronic lung disease, ROP=retinopathy of prematurity 
Author/Year Study Design 
Level of Evidence 
Study Purpose/Study Sample 








I Purpose: To assess the effects of 
interventions for prevention of 
neonatal hyperglycemia in infants 
with birth weights less than 1,500 
grams receiving or intending to 
receive total or partial parenteral 
nutrition 
 
Sample: 4 RCTs involving infants 
less than 32 weeks gestation and birth 
weight less than 1,500 grams 
receiving or intended to receive 
parenteral nutrition without 
hyperglycemia at the start of the 
study.  
 
Intervention: Restriction versus no 
restriction of glucose infusion. 
 
Insulin therapy versus restriction in 
the rate of glucose infusion. 
 
Insulin therapy versus no restriction in 
the rate of glucose. 
 
Primary Outcomes: mortality, 
neurodevelopmental impairment, 
growth at 36 weeks PCA, blood 
glucose concentrations 
 
Secondary outcomes: caloric intake, 
cumulative parenteral glucose intake, 
hypoglycemia, nitrogen accretion, 
sepsis, NEC, CLD*, length of hospital 
stay, and levels of insulin growth 
factor. 
Insufficient evidence exists to 
inform clinical practice on the rate 
of glucose infusion. 
 
Insulin decreases blood sugar 
levels but its use to prevent 
hyperglycemia is not 
recommended for practice as it is 
associated with death before 28 










I Purpose: To examine the effects of 
interventions for treating neonatal 
hyperglycemia in the very low birth 
weight infant who is receiving total or 
partial parenteral nutrition. 
 
Sample: 2 RCTs involving infants 
with birth weight less than 1,500 
grams and born at less than 32 weeks 
gestation. 
 
Intervention: Reduction of glucose 
infusion rate versus no reduction in 
glucose infusion rate. 
 
Insulin infusion versus no reduction in 
glucose infusion rate. 
 
Insulin infusion versus reduction in 
glucose infusion rate. 
 
Primary outcome: all cause 
mortality, neurodevelopmental 
impairment, severe IVH, ROP*, 
bacterial and fungal sepsis 
 
Secondary outcomes: time to resolve 
hyperglycemia, recurrent episodes of 
hyperglycemia, hypoglycemia, caloric 
intake, NEC, duration of mechanical 
ventilation, CLD*, and length of 
hospital stay. 
Insufficient evidence exists to 
determine if treatment 
interventions for hyperglycemia 
are associated with an increased 
risk of morbidity or mortality. 
 
Insulin infusion was associated 
with a higher intake of energy and 
glucose resulting in improvement 
in short term growth, but the 
importance of these outcomes 







Early Aggressive Nutrition 
PICO Question: Does an early aggressive nutrition plan that includes early administration 
of amino acids, intralipids, and minimal enteral feedings improve growth of the ELBW 
infant? 
Search Terms: total parenteral nutrition, amino acid intake, protein intake, intravenous 
amino acids, intravenous fat emulsion, intralipid, intravenous fat, lipid infusion, 
parenteral lipid, lipid emulsion, trophic feedings, minimal enteral feedings, growth, 
premature infant, low birth weight infant, very low birth weight infant, and extremely low 
birth weight infant. 
Summary of findings:  
Clinical studies to determine the best nutritional method for promoting growth in 
the ELBW infant are minimal. Most studies include very low birth weight (VLBW) 
infants who weigh less than 1,500 in order to obtain an adequate sample size. Two RCTs 
have shown that an early aggressive nutritional regimen leads to an improved caloric 
intake within the first few days of life as well as a positive nitrogen balance. In one of the 
RCTs early aggressive nutrition was associated with improved growth within the first 
week of life and prior to discharge. 
 Part of early nutrition requires the administration of amino acids and intralipids 
shortly after birth. Eleven RCTs have been conducted to examine the effect of early 
administration versus the late administration of amino acids in premature infants with 
birth weights ranging from 500 grams to 2,000 grams. The early administration of protein 
has been shown to prevent catabolism, promote nitrogen balance and protein synthesis 
without increasing blood urea nitrogen (BUN) levels and disrupting acid base balance. A 
28 
 
systematic review of early intralipid administration found that no adverse effects were 
associated with intralipid administration but its use could not be recommended for 
promoting short term growth. 
 Minimal enteral feedings (MEF) or trophic feedings are the last component of an 
early aggressive nutrition plan. In a systematic review trophic feedings were found to 
have no statistical effect on growth or development, but no harm or adverse effects 
including NEC were found to be associated with administering trophic feedings. These 
findings were further supported in another systematic review that found delaying enteral 





























Table 5: Early Aggressive Nutrition 
 
Author/Year Study Design 
Level of Evidence 
Study Purpose/Study Sample 
Study Intervention/Study Outcome 
Results GRADE Quality 
of Evidence 
Early Aggressive Nutrition 
Ibrahim, et al., 2004 RCT II Purpose: To determine if early 
aggressive TPN vs. late TPN will 
improve nitrogen and energy balance. 
To determine if any complications 
with early aggressive TPN will occur. 
 
Sample: 32 infants with birth weights 
between 501 to 1250 grams and 
gestational ages of 24 to 32 weeks. 
 
Intervention: Early TPN: 3.5g/kg/d 
of AA* +3g/kg of IL* within 2 hours 
of birth  versus Late TPN: Dextrose 
and 2g/kg AA* at 48h of life + 
0.5g/kg of IL* 48h after, which both 
increased by 0.5g/kg/d to a max of 
3.5g/kg AA* and 3g/kg IL* 
 
Primary outcomes: Nitrogen balance 
and caloric intake. 
 
Secondary outcomes: BPD, IVH, 
PDA, ROP*, and sepsis. 
Early TPN= higher nitrogen 
retention, higher caloric intake 
within 5 days of life and greater 
mean serum bilirubin levels with 
no clinical difference. 
 
Late TPN group= higher mean 
serum glucose concentrations. 




No blinding of 
intervention 
Wilson et al., 1997 RCT II Purpose: To improve energy intake in 
sick VLBW infants; to decrease 
growth problems, lessen pulmonary 
morbidity, shorten hospital stay, and 
avoid possible feeding related 
morbidities with an early aggressive 
nutrition regimen. 
 
Sample: 125 infants with birth weight 
less than 1,200 grams or infants with 
birth weights of 1,200 to 1,499 grams 
requiring mechanical ventilation 
within 24 hours of birth 
 
Intervention: Control group: Glucose 
alone until DOL 3 
AA* 1g/kg/d on DOL 3 advanced by 
0.5/g/kg/d to max of 2g/kg/d; IL* 
0.5g/kg/d on DOL* 5 advanced by 
0.5g/kg/d to max of 2g/kg/d 
Enteral feeds introduced when 
clinically stable. 
 
Treatment Group: Glucose +AA* at 
0.5g/kg advanced by 0.5g/kg/d to a 
max of 3.5g/kg/d; IL* 0.5g/kg/d 
started DOL* 2 advanced by 
0.5g/kg/d to max of 3.5g/kg/d. Enteral 
feeds 0.5ml/h at 12h of life. 
 
Outcomes: time to regain birth 
weight, days of oxygen therapy, days 
of mechanical ventilation and days to 
discharge. 
Infants who received early 
aggressive nutrition had higher 
energy intake with less weight 
loss after birth and took less time 
to regain their birth weight. 
 
Infants in the treatment group had 
improved weight gain, length and 
head circumference at discharge. 
 
No difference was found in length 










to help control 
for blinding. 
 
 Observers of 
biochemical and 
radiological data 
were blinded to 
group 
assignment. 
Early Administration of Protein 
Anderson, Beiber & 
Heird, 1979 
 
RCT II Purpose: To determine the efficacy of 
two isocaloric nutrition regimens 
administered intravenously. 
 
Sample: 14 preterm infants 
appropriate for gestational age whose 
clinical condition precluded oral 
feedings for at least 5 days. 
 
Intervention: IV glucose vs. glucose 
+ 2g/kg/day of AA* given for 5 days. 
 
Outcomes: electrolytes, BUN, acid 
base status, plasma AA* levels, 
nitrogen balance. 
Infants who received AA* had 
positive nitrogen balance. 
 
Infants who received glucose 
alone had significantly lower total 
essential AA* and total AA* 
concentrations.  
 
Infants who received AA* 





No blinding and 





Blanco et al., 2011 
 
RCT II Purpose: To examine changes in 
plasma AA* levels over time when 
ELBW infants are provided standard 
AA* supplementation or an early and 
high AA* supplementation. 
 
Sample: 62 ELBW infant less than 12 
hours of age. 
 
Intervention: AA* at 0.5g/kg/day 
started within 24 to 36 hours of life 
and advanced by 0.5g/kg/day to a 
maximum of 3g/kg/d and continued 
for 7 days vs. AA* at 2g/kg/day 
started within 24 hours of life and 
advanced by 1g/kg/day to a maximum 
of 4g/kg/day and continued for 7 days. 
 
Outcomes: AA* Levels 
Total AA* concentrations, 
including essential and 
nonessential AA* concentrations 
were higher in the early and high 
AA* group. Essential and total 
AA* concentrations were higher 
at day 1 and 3 in the early and 
high AA* group. Non-essential 
AA* concentrations were only 
different on day 3 in the early and 





Clark, Chase & 
Spitzer, 2007 
 
RCT II Purpose: To measure the effects of 2 
distinct strategies for parenteral 
nutrition on neonatal growth and 
blood AA* profiles. 
 
Sample: 122 infants born at 23-29 6/7 
weeks gestational age 
 
Intervention:  2.5g/kg/day of AA* 
(started at 1g/kg/d and advanced by 
0.5g/kg/d-low group) vs. 3.5g/kg/day 
of AA* (started at 1.5g/kg/d and 
advanced by 1g/kg/d-high group). IL* 
started at same time as TPN at 
0.5g/kg/d and advanced by 0.5/kg/d. 
GIR* rate 8-12mg/kg/min; no use of 
Insulin. AA* limited to 1g/kg/d for 
low AA* group; 2g/kg/d for high 
AA* group when feeds at 80-
100ml/kg/d. Completed treatment 
once on full feedings. 
 
Outcome: growth and plasma AA* 
levels. 
No difference between the two 
groups for growth or morbidities; 
Infants in the high AA* group 
had higher AA* levels than the 











II Purpose: To compare the 
biochemical tolerance of 3 different 
parenteral nutrition regimens 
administered within the first 48 hours 
of life. 
 
Sample: 29 infants with birth weight 
less than 2,000 grams who could not 
receive enteral feedings directly after 
birth. 
 
Intervention: 10% glucose infusion 
vs. 10% glucose infusion + AA* vs. 
10% glucose infusion + AA* + IL* 
 
Outcomes: AA* profile, cholesterol, 
triglycerides, acid base status, glucose 
levels. 
Plasma AA* fell immediately in 
the glucose only group. 
Hypoglycemia occurred more 
frequently in the glucose + AA* 
group and the least commonly in 
the glucose +AA*+ IL*. No 
difference in the groups for 
triglyceride and cholesterol levels 













RCT II Purpose: To determine whether early 
administration of parenteral AA* is 
associated with better growth and 
neurodevelopmental outcomes 
 
Sample: 1,018 infants with birth 
weight of 401 to 1,000 grams and 
enrolled within 72 hours of life. 
 
Intervention: Administration of 
3g/kg/day or greater of AA* within 
first 5 days of life (early) vs. less than 
3g/kg/day of AA* given in the first 5 
DOL* (late). 
 
Outcomes: growth (weight, length 
and head circumference) and 
neurodevelopmental outcomes. 
 
Significant difference in weight, 
length and head circumference at 
36 weeks post conceptual age in 
favor of early AA* group. 
 
The odds of having a weight less 
than the 10th percentile was 4 fold 
higher in the late AA* group with 
male infants twice as likely to 
have a head circumference below 
the 10th percentile. 
 
No difference was found in 
neurological or developmental 
outcomes or growth parameters 
between the 2 groups at 18 








Rivera, Bell & Bier, 
1993 
 
RCT II Purpose: To provide information on 
the safety and efficacy of AA* 
administration to low birth weight 
infants during the first 3 days of life. 
 
Sample: 23 preterm infants with RDS 
requiring mechanical ventilation and 
indwelling arterial catheters during 
the first 3 days of life. 
 
Intervention: Glucose alone vs. 
glucose +1.5g AA*/kg/day 
administered on the first day of life. 
 
Outcomes: nitrogen balance, AA* 
levels, protein kinetics, electrolytes, 
ammonia, and BUN levels. 
Infants who received AA* had 
positive nitrogen balance, whole 
body protein balance as a result of 
increased protein synthesis. 
 
Early administration of AA* was 
deemed safe with no differences 







TeBraake, Van Den 
Akker, Wattimena, 
Huijmans & Van 
Goudoever, 2005 
 
RCT II Purpose: To test the administration of 
2.4grams AA*/kg/d in VLBW infants 
to see if it is safe and results in 
positive nitrogen balance. 
 
Sample: 135 premature infants with 
birth weight equal to or less than 1500 
grams. 
 
Intervention: Administration of 
2.4g/kg/d of AA* within 2H of birth 
and 5.5mg/kg/min of Glucose 
(treatment group) versus glucose at 
5.5mg/kg/day after birth, with 
administration of 1.2g/kg/d AA* on 
the first day of life and advancement 
to 2.4g/kg/d on the third day of life 
(control group). 
 
Outcomes: Nitrogen balance, AA* 
concentrations, metabolic acidosis, 
and glucose levels. 
Treatment group had more infants 
who received prenatal steroids. 
 
Treatment group had higher BUN 
levels on Day 2 with no 
difference in levels on Day 4. 
 
Treatment group had improved 
nitrogen intake, positive nitrogen 
balance on day 2, and higher AA* 
levels. 
 
No adverse effects were found 






not blinded to the 
intervention and 





Fennessey & Hay, 
2003 
 
RCT II Purpose: To assess the safety and 
efficacy of early AA* intake 
mimicking intrauterine accretion rates 
 
 
Sample: 28 infants with birth weight 
less than or equal to 1,300 grams and 
requiring mechanical ventilation. 
 
Intervention: 1g/kg/d of AA* versus 
3g/kg/d of AA* given intravenously. 
 
Outcomes: protein balance, acid base 
status, and BUN levels. 
Infants receiving 3g/kg/d of AA* 
had increased protein accretion 
through increase protein synthesis 
rather than through the prevention 
of protein breakdown. 
 
No significant difference in 
metabolic acidosis, use of sodium 









Van Goudoever, et 
al., 1995 
 
RCT II Purpose: To gain information on 
protein kinetics after AA* 
supplementation. 
 
Sample: 18 preterm infants less than 
2,000 grams needing mechanical 
ventilation and umbilical catheters. 
 
Intervention: Glucose only (control) 
vs. Glucose + AA* delivered after 
birth. 
 
Outcomes: nitrogen balance, protein 
synthesis, AA* profile, blood pH, 













No difference in blood pH, base 
excess, urea concentration or 
glucose levels.  
 
Total AA* concentration and 
essential AA* concentration were 
significantly lower and below 
references ranges in the control 
group.  
 
Nitrogen retention was improved 
in the treatment group.  
 
Improved protein balance due to 
enhanced protein synthesis rather 
than increased protein 
breakdown.  
 
Cysteine levels were highly 
predictive for protein synthesis in 

















RCT II Purpose: To evaluate the effect of 
AA* administration given during the 
second day of life on protein turnover 
and nitrogen balance. 
 
Sample: 18 preterm infants 
appropriate for gestational age 
 
Intervention: Glucose alone was 
administered to both groups on the 
first postnatal day. Group A: glucose 
+ AA*+IL* versus Group B: glucose 
+ IL* until postnatal day 4 when AA* 
were added to the regimen. 
 
Outcomes: protein turnover and 
nitrogen balance. 
Group A had higher protein flux 
and higher protein synthesis.  
 
No difference in protein 
breakdown between the 2 groups.  
 
Administration of AA* resulted 
in positive nitrogen balance.  
 
No adverse effects of AA* 









Early Administration of Intralipids 










I Purpose: To assess the effect of early 
administration of IL* on growth, the 
risk of CLD* and other respiratory 
morbidities, NEC, IVH, ROP*, PDA, 
sepsis, thrombocytopenia, jaundice, 




Sample: 7 RCTs assessing the effect 
of early versus late administration of 
IL* 
 
Intervention: Early introduction of 
IL* (less than 5 DOL*) versus late 
introduction of IL* (greater than 5 
DOL*) 
 
Primary Outcomes: weight, length, 
head circumference, incidence CLD*, 
death 
 
Secondary Outcomes: respiratory 
morbidities, NEC, PDA, ROP*, IVH, 
sepsis, thrombocytopenia, and 
jaundice. 
The early administration of IL* 
has no statistically significant 
effect on short term nutrition or 
other clinical outcomes. 
 
Neither benefits nor adverse 
outcomes were found in 
administering IL* early. 
 
The use of early administration of 
IL* cannot be recommended for 
short term growth or to prevent 


















I Purpose: To determine the effect of 
trophic feedings on feeding tolerance, 
growth and development, the 
incidence of NEC, infection, and 
mortality. 
 
Sample: 8 RCTs investigating trophic 
feedings in infants less than 32 weeks 
gestation and weighing less than 
1,500 grams at birth. 
 
Intervention: Early trophic feeding 
(milk volumes up to 24ml/kg/day) 
within 4 days of birth continued for at 
least 7 days vs. enteral fasting for 1 
week. 
 
Primary Outcomes: feeding 
tolerance, NEC. 
  
Secondary Outcomes: mortality prior 
to discharge, growth, 
neurodevelopment, infection, 










Trophic feedings do not have a 
statistically significant effect on 
feeding tolerance, growth and 
development, NEC, infection or 
mortality.  
 
Trophic feedings were not 














I Purpose: To determine the effect of 
delaying the advancement of enteral 
feedings on the incidence of NEC, 
mortality and other morbidities in 
very low birth weight infants 
 
Sample: 5 RCTs with 600 premature 
infants less than 32 weeks gestation 
with birth weights less than 1,500 
grams 
 
Intervention: Delayed advancement 
of enteral feeds (more than 4 days 
after birth) vs. early advancement of 
enteral feedings 
Primary Outcomes: NEC and all 
cause mortality during the neonatal 
period and prior to hospital discharge. 
 
Secondary Outcomes: growth (short 
term and long term), 
neurodevelopment, time to establish 
full enteral feeding, time to establish 
oral feedings, feeding intolerance, 
incidence of invasive infection and 
length of stay. 
Delaying the advancement of 
enteral feedings does not reduce 







Note. AA= amino acids, CLD=chronic lung disease, DOL= day of life GIR=glucose infusion      




















PICO Question: What type of feeding (human milk or formula) promotes growth and has 
the least adverse outcomes for the ELBW infant? 
Search Terms: human milk, breast milk, formula, term formula, preterm formula, 
premature infant, low birth weight infant, very low birth weight infant, extremely low 
birth weight infant 
Summary of findings: 
 No RCTs have been done comparing maternal human milk to formula due to the 
ethical implications of conducting such a study. A systematic review compared donor 
human milk to formula and found those infants fed formula had a higher incidence of 
NEC. The AAP Section on Breastfeeding (2005) developed a policy statement for 
exclusive human milk feeding of all newborns including premature infants until at least 
six months of age. 
Table 6: Human Milk 
 
Author/Year Study Design 
Level of Evidence 
Study Purpose/Study Sample 

























Purpose: To determine the effect of 
feeding with formula vs. donor 
human milk on growth and 
development and adverse outcomes in 
preterm low birth weight infants 
 
Sample: 8 RCTs with 1,107 clinically 
stable preterm infants born at less 
than 32 weeks gestational age. 
  
Intervention: Formula milk feeding 
versus donor human milk feeding 
 
Primary Outcomes: short and long 
term growth, neurodevelopmental 
outcomes at 12months, severe 
neurodevelopmental disability, 
cognitive and educational outcomes at 
more than 5 years of age. 
 
Secondary Outcomes: mortality, 
NEC, time to establish full feedings, 
feeding intolerance, sepsis. 
Infants who were fed formula 
had higher rates of short term 
growth when compared to 
infants fed donor human milk. 
 
 Formula feeding was 
associated with a higher risk 
of developing NEC. No effect 
was found on long term 










PICO Question: Should feedings in the ELBW infant be given through an orogastric or 
nasogastric feeding tube? 
Search Terms: feeding tube, feeding methods orogastric (OG) feedings, nasogastric (NG) 
feedings, premature infant, low birth weight infant, very low birth weight infant, and 
extremely low birth weight infant 
Summary of findings:  
 One systematic review found insufficient evidence to support the routine use of 
nasogastric or orogastric tube feedings in preterm infants. 






Author/Year Study Design 
Level of Evidence 
Study Purpose/Study Sample 














I Purpose: To determine the effect of 
feeding tube placement (nasogastric 
(NG) vs. orogastric (OG)) on feeding, 
growth and development, and adverse 
consequences in preterm or low birth 
weight infants. 
 
Sample:  2 RCTs of preterm infants 
less than 37 weeks gestational age or 
low birth weight infants less than 
2,500 grams 
 
Intervention: Enteral feedings given 
via NG route versus the OG route 
 
Primary Outcomes: time to establish 
full enteral feedings, time to regain 
birth weight, growth assessed at 
intervals starting at 6 months of age. 
 
Secondary Outcomes: time to 
establish full oral feedings, time to 
extubation, time to be without oxygen 
supplementation, duration of hospital 
stay, and adverse events (apnea, 
pneumonia, NEC, gastric or 
esophageal perforation, nasal 
deformities, and neurodevelopmental 
outcomes) 
Insufficient evidence to support 
routine use of either NG or OG 







Time of feeding administration 
PICO Question: Should feedings in the ELBW infant be administered as an intermittent 
bolus or as a continuous infusion? 
Search terms: feeding methods, continuous, intermittent, enteral nutrition, enteral 
feedings, premature infant, low birth weight infant, very low birth weight infant and 
extremely low birth weight infant 
Summary of findings: 
 One systematic review found no difference in feeding administration on the 
incidence of NEC but insufficient evidence exists to recommend continuous feedings or 
intermittent bolus feedings. The American Dietetic Association (ADA) Pediatric 
Nutrition Practice Group (2009) points out that continuous feedings may be appropriate 
in the ELBW infant who exhibits signs of feeding intolerance or gastroesophageal reflux 
(GER).   
Table 8: Timing of Feeding Administration 
 
Author/Year Study Design 
Level of Evidence 
Study Purpose/Study Sample 
Study Intervention/Study Outcome 
Results GRADE Quality 
of Evidence 











I Purpose: To determine the 
effectiveness of continuous versus 
intermittent gavage feeding as a 
feeding strategy in preterm infants 
weighing less than 1,500 grams. 
 
Sample: 7 RCTs with 511 premature 
infants with birth weight less than 
1,500 grams 
 
Intervention: Continuous enteral 
feedings vs. intermittent bolus enteral 
feedings 
 
Primary Outcomes: feeding 
intolerance, days to regain birth 
weight, age at full enteral feedings, 
age at discharge, somatic growth, and 
NEC 
 
Secondary Outcome: Apnea 
No difference was found in 
continuous or intermittent 
enteral feedings on the time to 
reach full enteral feedings 
regardless of tube placement.  
 
The reports of NEC between the 
two methods of feeding were 
similar.  
 
Authors concluded not enough 
evidence exists to determine the 
best feeding method for preterm 
infants with birth weight less 











Rate of Feeding Advancement 
PICO Question: Should feedings be advanced at a slower or faster rate in order to 
promote growth and prevent NEC in the ELBW infant? 
Search Terms: feeding advancement, growth, NEC, premature infant, low birth weight 
infant, very low birth weight infant, and extremely low birth weight infant. 
Summary of findings: 
 One systematic review determined that the rate of feeding advancement did not 
increase the incidence of NEC and increasing feedings at a faster rate of 30-35ml/kg/day 
was associated with a decrease in the time to reach full feedings and regain birth weight. 
The authors of the systematic review recommended using caution when advancing 
feedings at a faster rate in the ELBW infant due to the small number of ELBW infants 
included in the systematic review. 
Table 9: Rate of Feeding Advancement 
 
Author/Year Study Design 
Level of Evidence 
Study Purpose/Study Sample 









I Purpose: To determine the effect of 
slowly advancing enteral feedings on 
the incidence of NEC, mortality and 
other morbidities in very low birth 
weight infants. 
 
Sample: 4 RCTs with a total of 496 
premature infants less than 32 weeks 
gestation and birth weight less than 
1,500 grams 
 
Intervention: Advancement of 
feedings at a maximum rate of 
24ml/kg/day vs. faster advancement  
(30-35 ml/kg/day) of feedings 
 
Primary Outcomes: NEC and all 
cause mortality during the neonatal 
period and prior to hospital discharge 
 
Secondary Outcomes: growth, 
neurodevelopment, time to establish 
full enteral feeding, feeding 
intolerance, infection and length of 
stay. 
Slowly advancing enteral feedings 
does not reduce the risk of NEC 
but it decreases the amount of 
time for an infant to regain their 
birth weight and the amount of 
time to establish full enteral 
feedings.  
 
Length of stay was not affected 












Human Milk Fortification 
PICO Question: Does human milk fortification improve growth in the ELBW infant? 
Does fortification with higher amounts of protein improve growth in the ELBW infant? 
Search Terms: human milk fortification, growth, enteral protein, protein, protein 
fortification, premature infant, low birth weight infant, very low birth weight infant, and 
extremely low birth weight infant 
Summary of findings: 
 One systematic review done in preterm infants found that human milk 
fortification with a multi-component human milk fortifier is needed to improve growth 
and support bone mineralization. Another systematic review found that additional protein 
supplementation of 3-4g/kg/day is needed to promote adequate growth in infants 




























Table 10: Human Milk Fortification 
 
Author/Year Study Design 
Level of Evidence 
Study Purpose/Study Sample 









I Purpose: To determine if human 
milk fortification with a multi-
component fortifier improved growth, 
bone metabolism and 
neurodevelopmental outcomes 
without significant adverse effects in 
preterm infants. 
 
Sample:13 RCT with over 600 
preterm infants 
  
Intervention: Fortified human milk 
feedings vs. non-fortified human milk 
feedings during the NICU stay. 
 
 
Primary Outcomes: growth to 
discharge, size at 12-18 months, bone 
metabolism, and neurodevelopmental 
outcomes 
 
Secondary Outcomes: fractures, 
nitrogen retention, adverse effects 
(hypercalcemia, GI* disturbances, 
feeding intolerance, diarrhea, NEC, 
blood pH, BUN levels, death). 
Human milk fortification improves 
short term weight gain, linear and 
head growth as well as possible 
bone formation without adverse 
effects.  
 
No long term benefits of human 











I Purpose: To determine the effect of 
higher versus lower protein intakes of 
formula fed preterm infants on 
growth and neurodevelopment 
  
Sample: 5 RCTs of formula fed 
hospitalized infants less than 2,500 
grams 
 
Intervention: higher enteral protein 
intake v lower enteral protein intake 
 
Primary Outcomes: growth, 
nitrogen utilization and accretion, IQ 
scores, 18month Bayley Scores, 
growth failure, phenylalanine levels 
 
Secondary Outcomes: gastric 
motility, days to full feedings, 
feeding intolerance, NEC, metabolic 
acidosis, serum albumin, sepsis, and 
diarrhea. 
 
Increased protein intake (3-
4g/kg/day) improved weight gain by 
2g/kg/day, which was associated 
with increased lean body mass. 
 
No difference in phenylalanine 
levels. 
 
Limited evidence on long term 
















Post Discharge Nutrition 
PICO Question: Should the ELBW infant continue to receive fortified human milk after 
discharge to improve growth? Should the ELBW infant continue to receive premature 
infant formula after discharge to improve growth?   
Search Terms: post discharge nutrition, human milk fortification, premature infant 
formula, infant nutrition, premature infant, low birth weight infant, very low birth weight 
infant, and extremely low birth weight infants. 
Summary of findings: 
 The evidence for post discharge nutrition involves mostly premature infants 
without a focus on the ELBW infant. A case control study done in ELBW infants found 
an increase their total energy expenditure at discharge when compared to term infants. 
Two systematic reviews address post discharge nutrition in the premature infant, less than 
37 weeks gestation. One systematic review compared fortified human milk to plain 
human milk after discharge and found an improvement in growth but the review was 
limited to 1 RCT. A second systematic review compared nutrient enriched premature 
infant formula to a standard term infant formula after discharge and determined the use of 
a nutrient enriched premature infant formula was not necessary after discharge in infants 
who were able to tolerate ad libitum feedings. The AAP Committee on Nutrition (2004) 
recommends premature infants especially those born at lower gestational ages receive 
fortified human milk or nutrient enriched premature formula until at least 9 months of age 






Table 11: Post Discharge Nutrition 
 
Author/Year Study Design 
Level of Evidence 







Coltart, Leitch & 
Denne, 2008 
Case Control IV Purpose: To determine total 
energy expenditure in ELBW 
infants at discharge in comparison 
to term infants  
 
Sample: 10 ELBW infants on full 
feedings for at least 3 weeks and 
receiving fortified human milk or 
a post-discharge formula, 14 
healthy term infants being 
breastfed at time of the study 
 
Intervention: Double labeled 
water method to determine energy 
expenditure 
 
Outcomes: energy expenditure 
Total energy expenditure was 
significantly higher in the ELBW 
infant estimated to be greater than 
90kcal/kg/day despite higher energy 
intake at about 130kcal/kg/day. 
 
The ELBW infant had more lean fat 
free mass than their term 
counterparts. 
 
Correction for fat free mass continued 
to show significantly higher energy 
expenditure in the ELBW infant. 
 
Weight gain in the ELBW infant was 











I  Purpose: To determine the 
effects of nutrient enriched 
formula fed after discharge from 
the NICU on the preterm infant’s 
growth and development 
Sample: 7 RCTwith 631 preterm 
infants partially fed formula 
following discharge from the 
NICU. 
 
Intervention: Nutrient enriched 
formula feedings versus standard 
term infant formula feeding. 
 
Primary Outcomes: short and 
long term growth, 
neurodevelopmental outcomes at 
12months of age, severe 
neurodevelopmental disability, 
and cognitive and educational 
outcomes at more than 5 years of 
age. 
 
Secondary Outcomes: bone 
mineralization, feeding 
intolerance, clinical evidence of 
rickets, blood pressure readings, 
and BMI* at long term follow up. 
Infants fed nutrient enriched formula 
ad libitum after discharge from the 
NICU had no statistical difference in 
growth, neurodevelopment, bone 











I Purpose: To determine effect of 
plain human vs. multi-nutrient 
fortified human milk on growth 
and development of the premature 
infant 
 
Sample: 1 RCT of 39 preterm 
infants less than 33 weeks 
gestational age 
 
Primary Outcomes: growth 
during the study period, long term 
growth and growth restriction, 
neurodevelopmental outcomes, 
and education and cognitive 
outcomes at greater than 5 years 
of age 
 
Secondary Outcomes: bone 
mineralization, feeding 
intolerance, duration of breast 
feeding, and evidence of rickets, 
blood pressure values, and BMI* 
at long term follow up. 
Feeding preterm infants with multi-
nutrient fortified human milk 
improves growth during infancy but 
further trials are needed to confirm 












PICO Question: What parameters should be used to monitor growth in the ELBW infant? 
What laboratory assessments should be done to monitor the nutritional status of the 
ELBW infant? How often should laboratory assessments be done to monitor the 
nutritional status of the ELBW infant? 
Search Terms: laboratory assessment, nutritional assessment, growth assessment, 
premature infant, low birth weight infant, very low birth weight infant, and extremely low 
birth weight infant 
Summary of findings:  
 No clinical trials or observational studies have been done to address what 
parameters or laboratory data should be used to monitor nutrition in the ELBW infant. 
The ADA Pediatric Nutrition Practice Group (2009) provides recommendations for 
laboratory assessment of nutrition in premature infants. Moyer-Mileur (2007) provides 
recommendations for anthropometric measurements and laboratory assessment for 













ACE STAR MODEL OF KNOWLEDGE TRANSFORMATION 
The ACE Star Model of Knowledge Transformation provides a framework for 
understanding the concepts and processes utilized in the implementation and integration 
of EBP (Stevens, 2004). This model is a five point star that depicts the five different 
stages of knowledge transformation. The stages of knowledge transformation include 
discovery, summary, translation, integration and evaluation (Stevens, 2004). Each stage 
of knowledge transformation builds upon the previous stage of knowledge leading to 
newly discovered knowledge and information that may be used and implemented into 
clinical practice.  
Discovery 
The first stage of knowledge transformation or star point is discovery where new 
knowledge is generated (Stevens, 2004). In this stage, knowledge may be gained from 
conducting primary research studies or through a review of the literature to determine 
best clinical practices. The knowledge generated from either primary research studies or a 
literature review may then be used to guide clinical care decisions. 
Summary 
 The second stage of knowledge transformation or star point is summary and is 
directly related to the EBP process. In this stage, primary research studies from a 
literature review are summarized into a meaningful and concise statement. The summary 
of evidence is usually done in the form of a systematic review or meta-analysis (Stevens, 
2004). A systematic review or meta-analysis is considered to be the highest level and best 
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evidence that should be used to guide clinical practice (Melnyk & Fineout-Overholt, 
2010). 
Translation 
 The third stage of knowledge transformation or star point is translation. 
Translation is taking the summary of evidence in a systematic review or meta-analysis 
and developing a CPG to guide and standardize clinical practice (Stevens, 2004).   
Integration 
The fourth stage of knowledge transformation or star point is integration where new 
knowledge such as a CPG is implemented and used in clinical practice. Integration 
involves making and promoting change within the individual and the organization. 
Utilizing CPGs based on the highest level and quality of evidence promotes EBP in the 
clinical setting and will serve to improve clinical outcomes (Newhouse et al., 2007). 
Evaluation 
The last stage of knowledge transformation or fifth star point is evaluation. 
Evaluation involves assessing the outcome of the EBP change (Stevens, 2004). The 
outcomes may include clinical care outcomes, patient satisfaction, system efficiency or 
efficacy as well as a cost analysis. This final stage of knowledge transformation is 
imperative to the EBP process so that the desired effect or outcome may be evaluated and 
further clinical practice improvements can be made. 
The ACE Star Model of Knowledge Transformation utilizes a five step process 
for understanding knowledge transformation, which can be applied to learning and 
implementing EBP. The third and fourth points of the ACE Star Model are the most 
congruent with the development and dissemination of this CPG.  This guideline was 
45 
 
developed using the highest level of evidence available to guide neonatal health care 
providers in managing the daily nutrition of ELBW infants so that postnatal growth and 








This doctoral project was submitted to the University of Nevada Las Vegas 
Institutional Review Board in April of 2011. The project was reviewed according to the 
federal regulatory statutes 45CFR46 and it was deemed exempt from needing IRB 
approval. 
THE PROJECT 
The EBP process was used in developing this CPG to address the nutritional 
management of the ELBW infant. The process included: developing a clinical question 
using the PICO format, completing an extensive review of the literature, categorizing the 
level of evidence, and evaluating the quality of evidence and strength of 
recommendations to be included in the CPG. The PICO questions and specific terms used 
to search the literature are included with the review of the literature and resulting 
evidence tables located in Chapter 2. Consistent with the conceptual framework for this 
project, systematic reviews were used where available. 
 The level of evidence was rated utilizing the Melnyk & Fine-Overholt (2010) 
Rating System for the Hierarchy of Evidence, which is the National Association of 
Neonatal Nurses (NANN) preferred model for rating level of evidence when developing a 
CPG. The quality of evidence and strength of recommendations were evaluated using the 
GRADE System, which meets the IOM’s recommendations for evaluating the quality of 





Peer review and evaluation of this CPG will be completed by two NANN 
members. The NANN members will be doctorally prepared neonatal nurse practitioners 
who have served on the NANN Board of Directors and various other NANN committees. 
Each reviewer will be asked to use the NANN Instructions for Writing Clinical Practice 
Guidelines to evaluate the CPG for content validity. The peer review period is expected 
to take three months and will commence upon successful defense of this doctoral project. 
PRODUCT 
According to the IOM (2008) CPGs should be developed by expert panels that 
have knowledge regarding the clinical situation and have the ability to interpret clinical 
research to make sound clinical judgments.  The ultimate plan for this doctoral project is 
submission for publication, thereby transitioning this project into a product that may 
change practice.  Pending expert review (described above) and revisions if needed, this 
CPG will be submitted to NANN for publication. Neonatal nursing practice is governed 
by NANN, who has published several CPGs to guide the clinical management of 
critically ill neonates. Therefore, NANN would be the most appropriate site for 







This chapter presents the evidence based recommendations for the nutritional 
management of the ELBW infant. The recommendations are included in the table below 
and have been organized according to the NANN Guidelines for writing CPGs. The 
practice recommendation column includes the guidelines for practice and the rationale or 
supporting evidence for each practice guideline. The level of evidence column indicates 
the strength of evidence for each guideline and is followed by the GRADE quality of 
evidence and strength of recommendation. References in support of the practice 

















Table 12: Practice Recommendations and Rationale 
Practice Recommendation Level of 
Evidence 





The overall nutritional management of the ELBW 
should be based on intrauterine nutrient accretion 
rates to promote a weight gain of 15-20g/kg/day. 
 
Rationale: Nutrient accretion rates are considered the 
best reference for growth of ELBW infants (AAP 
Committee on Nutrition, 1985). The intrauterine rates 
of accretion have been determined utilizing published 
data on the chemical analysis of the fetus in order to 
provide a reference fetus comparable to the 
premature infant and the ELBW infant (Ziegler, et. 
al, 1976). 
VII Very Low Recommend (AAP Committee on 
Nutrition, 1985; Ziegler, 
O’Donnell, Nelson & 
Fomon, 1976) 
Fluid & Electrolyte Management 
Fluid intake will vary depending on the ELBW 
infant’s gestational and postnatal age, disease process 
and severity of illness. Fluid intake for the ELBW 
infant should be restricted to meet the infant’s 
physiologic needs.  
 
Rationale: Fluid restriction avoids excess water load 
on the immature kidney preventing fluid volume 
overload, which is associated with an increased 
incidence of NEC and PDA in premature infants. 
(Bell& Accareugi, 2010).  
I High Strongly 
Recommend 
(Bell & Accareugi, 2010) 
 
Fluid intake for the ELBW infant during the first 
week of life should be based on the amount of 
insensible water loss and urinary output. Fluid intake 
should start at 60-80ml/kg/day on the first day of life 
and be advanced by 10-20ml/kg/day throughout the 
first week of life to a maximum of 160-
170ml/kg/day. 
 
Rationale: Fluid management during the first week 
of life should allow for contraction of the 
extracellular fluid volume resulting in postnatal 
diuresis and a10-15% loss of birth weight. Failure to 
strictly manage fluid intake at such a critical time has 
been shown to increase the incidence of PDA and 
BPD in the ELBW infant (Oh et al., 2005; Stephens 
et al, 2008). 
IV Low Recommend (Oh et al., 2005; Stephens 
et al., 2008) 
 
The ELBW infant should be placed in a double 
walled isolette with ambient humidity of 70%-80% to 
aid in insensible water loss and fluid and electrolyte 
balance. 
 
Rationale: The ELBW infant is born with an 
immature non-keratinized epidermis resulting in 
insensible water loss through the immature skin layer. 
In two retrospective cohort studies, placement of 
ELBW infants in humidity was found to decrease 
total fluid intake, improved electrolyte balance and 
improve growth (Gaylord, et al., 2001; Kim, et al., 
2010). 
IV Low Recommend (Gaylord, et al., 2001; Kim, 
et al., 2010). 
 
 
After the first week of life when postnatal diuresis is 
complete, the goal of fluid management should shift 
from replacing water loss to providing enough 
nutrients for adequate growth. The target fluid goal 
for promoting adequate growth should be: 
 
140-160ml/kg/day and may be adjusted in 10-
20ml/kg/day increments until reaching the fluid goal. 
 
Rationale: Adequate fluid intake after postnatal 
diuresis is essential for adequate nutrient intake and 
postnatal growth. The recommended fluid intake 
promotes weight gain consistent with intrauterine 









VII Very Low Recommend (AAP Committee on 





Sodium should be withheld during the first 5 days of 
life to promote postnatal diuresis. After diuresis, a 
recommended daily intake of sodium at 2-
3meq/kg/day should be sufficient to meet the daily 
needs of the ELBW infant. 
 
Rationale: Sodium restriction during the first 5 days 
of age results in contraction of the extracellular fluid 
volume promoting postnatal diuresis (Shaffer & 
Meade, 1989). Infants who were supplemented with 
sodium within the first 5 days of life developed 
hypernatremia, required higher fluid intakes, and had 











(Costarino et al., 1992; 
Shaffer & Meade, 1989) 
 
(AAP Committee on 
Nutrition, 2004) 
 
Potassium should be held during the first 5 days of 
life until postnatal diuresis is complete. An intake of 
2-3meq/kg/day is recommended to the meet the daily 
needs of the ELBW infant. 
 
Rationale: The ELBW infant is at risk for 
developing non-oliguric hyperkalemia due to 
intracellular shifts in potassium during the first 5 days 








Recommend (Lorenz et al., 1997) 
 
(AAP Committee on 
Nutrition, 2004; ADA 
Pediatric Nutrition Group, 
2009) 
Mineral Requirements 
Calcium, phosphorus, and magnesium should be 
administered at a rate that mimics intrauterine 
accretion. Calcium intake should be 60-90mg/kg/day, 
phosphorus intake should be 47-70mg/kg/day, and 
magnesium intake should be 4.3-7.2mg/kg/day when 
receiving parenteral nutrition. Calcium and 
phosphorus should be administered in a 1:1 molar 
ratio. 
 
The recommended intake for calcium, phosphorus, 
and magnesium increases once the ELBW infant is 
on full enteral feedings. Calcium intake should be 
100-200mg/kg/day. Phosphorus intake should be 60-
140mg/kg/day. Magnesium intake should be 7.9-
15mg/kg/day. 
 
Rationale: Administering calcium, phosphorus, and 
magnesium to mimic intrauterine accretion rates 
improves bone mineral content decreasing the 
incidence of osteopenia of prematurity. In a RCT, 
administering higher doses of calcium and 
phosphorus within the first few days of life improved 
serum concentrations of phosphorus and bone 
mineral content from 1 week to 26 weeks 























(Prestridge et al., 1993) 
 







(ADA Pediatric Nutrition 
Practice Group, 2009)  
Energy Requirement 
Caloric intake for the ELBW infant should be 
supplied at the same intrauterine rate to promote 
optimal growth. Total caloric intake should be based 
on maintaining an energy balance of 25-
30kcal/kg/day, which is estimated to be: 
80kcal/kg/day to maintain body energy stores while 
receiving parenteral nutrition and should be the goal 
immediately after birth and within the first few days 
of life. 
 
105-115kcal/kg/day (including 3.5g/kg/day of amino 
acids) to promote growth while receiving parenteral 
nutrition. 
 
130-150kcal/kg/day to promote growth while 
receiving full enteral nutrition, additional protein may 
be needed to accompany the higher caloric intake. 
 
Rationale: Energy expenditure in the ELBW infant 
is estimated to be higher than the currently 
established values that are based on growing healthy 
premature infants (Carr, et al., 2000) Supplying 
additional calories along with an increased amount of 
protein has been shown to improve nitrogen retention 
















Recommend (Zlotkin et al., 1981) 
 
(Carr et al., 2000) 
 






Glucose intake for the ELBW infant shall be supplied 
at the same intrauterine rate to maintain adequate 
energy supply and should be administered directly 
after birth. Glucose infusion should start at: 
 
5-7mg/kg/min and be advanced as tolerated by 1-
2mg/kg/min to a maximum of 10-11mg/kg/day when 
receiving full parenteral nutrition. 
 
Rationale Glucose is the major source of energy for 
the fetal brain and is required to ensure adequate 
energy supply to the ELBW infant’s brain. 
Insufficient evidence exists to determine the exact 
rate of glucose utilization but experts suggest using 
the fetal rate of glucose utilization as a guide for 
administering glucose to the ELBW infant (Hay, 









Recommend (Sinclair et al., 2011) 
 
(AAP Committee on 
Nutrition, 2004; Hay, 
2005) 
 
In the ELBW infant hyperglycemia occurs frequently 
during the first week of life due to glucose 
administration.  Treatment of hyperglycemia may 
involve decreasing the glucose infusion rate or 
administering an insulin infusion but insulin should 
not be given to prevent hyperglycemia in the ELBW 
infant. 
 
Rationale: The exact cause of hyperglycemia seen in 
the ELBW during the first few days of life is still 
unknown but it is thought to be a result of glucose 
intolerance. Insufficient evidence exists to determine 
the exact method for treatment of hyperglycemia but 
insulin infusion to prevent hyperglycemia was found 
to be associated with an increase in death before 28 
days of age (Bottino et al., 2011; Sinclair et al., 
2011.) 













(Bottino et al., 2011; 
Sinclair et al., 2011) 
 
Early Aggressive Nutrition 
Early aggressive nutrition should be administered to 
the ELBW infant. The nutritional plan should include 
early administration of amino acids, intralipids and 
minimal enteral feedings (MEF). 
 
Rationale: An early aggressive nutrition plan 
improves caloric intake within the first week of life 
and promotes nitrogen balance (Ibrahim et al., 2004; 
Wilson et al., 1997). In a RCT, a nutrition plan that 
included early administration of amino acids, 
intralipids and MEF was shown to improve weight, 
length and head circumference of infants less than 
1,500 grams at discharge (Wilson, et al., 1997). 
II Moderate Strongly 
Recommend 
(Ibrahim et al., 2004; 
Wilson et al., 1997) 
 
Amino acids should start right after birth at a rate of 
3g/kg/day and should be increased by 0.5-1g/kg/day 
until reaching a maximum of 4g/kg/day. 
 
Rationale: Protein administration improves plasma 
amino acid levels, which promotes protein synthesis 
(Anderson, et. al, 1979; Blanco et al., 2011; Clark et 
al., 2007; Murdock et al., 1995; Rivera et al., 1993; 
TeBraake et al., 2005; Van Goudoever et al., 1995 
Van Lingen et al., 1992) Giving protein at 3g/kg/day 
is considered to be safe and mimics protein accretion 
rates seen in-utero as well as improves glucose 
tolerance (Thureen et al., 2003). Administering 
protein right after birth is safe and effective in 
preventing catabolism, promoting nitrogen and 
protein balance without increasing blood urea 
nitrogen (BUN) levels or disrupting acid base balance 
(Anderson et al., 1979; Rivera et al., 1993; TeBraake 
et al., 2005; Thureen et al., 2003; Van Goudoever et 
al., 1995; Van Lingen et al., 1992). The early 
administration of protein to ELBW infants has been 
shown to improve weight, length, and head 
circumference at 36 weeks postconceptual age 








II Moderate Strongly 
Recommend 
(Anderson et al., 1979; 
Blanco et al., 2011; Clark 
et al., 2007; Murdock et al., 
1995;; Poindexter et al., 
2006; Rivera et al., 1993; 
TeBraake et al., 2005; 
Thureen et al., 2003; Van 
Goudoever et al., 1995; 




Intralipids should start within 24 hours after birth at a 
rate of 0.5-1g/kg/day and should be increased by 0.5-
1g/kg/day until reaching a maximum of 3g/kg/day. 
Intralipids should be given continuously over 24 
hours. 
 
Rationale: The administration of intralipids prevents 
essential fatty acid deficiency and improves glucose 
tolerance (Anderson, et al., 1979; Murdock et al., 
1995). In a systematic review, early administration of 
intralipids was determined to be safe and have no 
adverse effects but could not be recommended for 
short term growth (Simmer & Rao, 2009). In a RCT, 
intralipids given as part of an early aggressive 
nutrition plan was found to improve growth of infants 
less than 1,500 grams within the first week of life and 









(Simmer & Rao, 2009) 
 
(Anderson et al., 1979; 
Murdock et al., 1995; 
Wilson et al., 1997) 
Minimal enteral feedings (MEF) should be started 
within the first 1 to 4 days of age at a rate of 10-
25ml/kg/day. Minimal enteral feedings should be 
given for at least 5 to 7 days. 
 
Rationale: In a RCT, MEF when given as part of an 
early aggressive nutrition plan was found to improve 
enteral intake and feeding tolerance without 
increasing the incidence of NEC (Wilson, et al., 
1997). Introducing MEF early within the first few 
days of life is further supported by two systematic 
reviews that found delaying feedings and the use of 
trophic feedings had no significant effect on the 
incidence of NEC (Bombell & McGuire, 2009; 













(Bombell & McGuire, 
2009; Morgan et al., 
2011a) 
 
(Wilson et al., 1997) 
Enteral Nutrition 
Human milk should be used for enteral feedings in 
the ELBW infant. Donor human milk should be used 
when maternal human milk is unavailable or is 
contraindicated. In cases where human milk 
(maternal or donor) is unavailable a premature infant 
formula may be used for enteral feedings but the use 
of formula should not be the feeding of choice. 
 
Rationale: Human milk is species specific and all 
other formula preparations are substantially different 
making human milk uniquely superior for infant 
feeding (AAP Section on Breastfeeding, 2005). 
Human milk contains immunoprotective and growth 
factors that protect the immature gut mucosa of the 
ELBW infant. Infants fed formula instead of human 
milk (maternal or donor) are have an increased risk 











(Quigley et al., 2008) 
 
 
(AAP Section on 
Breastfeeding, 2005) 
Enteral feedings may be administered through an oral 
or nasal gastric feeding tube. 
 
Rationale: The ELBW infant is not able to 
coordinate sucking and swallowing needed for oral 
nipple feedings placing them at high risk for 
aspiration. In addition, the ELBW infant’s immaturity 
and severity of illness prevents them from being able 
to tolerate nipple feedings, which requires enteral 
feedings to be administered via a feeding tube. 
Evidence is lacking to support the routine placement 
of feeding tubes in the nose or mouth (Hawes et al., 
2008). However, infants are obligate nose breathers 
and placing a feeding tube into their nares may lead 
to partial obstruction, increased airway resistance and 
increased work of breathing (Hawes et al., 2008). 
I High Strongly 
Recommend 
(Hawes et al., 2008) 
Enteral feedings may be given every 2-3 hours as an 
intermittent bolus or continuously via a feeding 
pump. 
 
Rationale: Insufficient evidence exists to determine 
the best feeding method for the ELBW infant. In a 
systematic review no difference in the incidence of 
NEC or time to reach full feedings was found 
between intermittent or bolus feedings (Premji & 
Chessell, 2011). Continuous feedings may be 
warranted in ELBW infants with feeding intolerance 
or those with symptoms of gastroesophageal reflux 












(Premji & Chessell, 2011) 
 
(ADA Pediatric Nutrition 
Practice Group, 2009) 
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Advancement of enteral feedings should take into 
consideration the ELBW infant’s gestational age and 
severity of illness. Enteral feedings may be advanced 
by 20-35ml/kg/day as tolerated until reaching full 
fluid intake at 140-160ml/kg/day.  
 
Rationale: Current evidence is lacking on the 
feeding advancement for the ELBW infant. In a 
systematic review, the rate of feeding advancement 
was not associated with an increased risk for NEC 
and slow advancement of feedings prolonged the 
need for parenteral nutrition and the time to regain 
birth weight in infants weighing less than 1,500 











(Morgan et al., 2011b) 
 
 
Human milk (maternal or donor) should be fortified 
with commercially available human milk fortifiers. 
Fortification of human milk should be done gradually 
to prevent feeding intolerance and may begin with 
22kcal/ounce when the infant is tolerating 
100ml/kg/day of enteral feedings and advanced as 
tolerated to 24kcal/ounce when the infant is tolerating 
full enteral feedings at 140-160cc/kg. If human milk 
is unavailable, the infant may be given a premature 
formula and should be advanced to 24kcal/ounce 
premature formula in the same manner as the infant 
receiving human milk. 
 
Rationale: The composition of human milk varies 
from person to person with protein, fat, and mineral 
content decreasing throughout lactation. The 
reduction of protein, fat and minerals in human milk 
fails to meet the nutritional needs of the ELBW 
infant. Fortifying human milk with commercial 
human milk fortifiers provides the additional amount 
of energy and protein needed for growth while 
providing adequate amounts of calcium and 
phosphorus to improve bone mineral content in the 
ELBW infant (Kuschel & Harding, 2009).  
 
The addition of human milk fortifiers increases the 
osmolality of the human milk and may result in 
feeding intolerance (ADA Pediatric Nutrition 
Practice Group, 2009).  Although human milk 
fortification is not associated with an increased risk 
of NEC (Kuschel & Harding, 2009) utilizing a step 
wise approach will help to prevent feeding 












(Kuschel & Harding, 2009) 
 
(Adamkin, 2009; ADA 
Pediatric Nutrition Practice 
Group, 2009) 
In addition to human milk fortification, enteral 
feedings should be supplemented with extra protein 
to reach a daily requirement of 3-4g/kg/day. If human 
milk is unavailable a premature infant formula with 
additional protein may be used.  
 
Rationale: The intrauterine accretion rate of protein 
to promote adequate growth is estimated to be 3-
4g/kg/day. In a systematic review, protein 
supplementation of enteral feedings at intrauterine 
accretion rates was found to improve nitrogen 
balance and promote weight gain in infants less than 




















I High Strongly 
Recommend 
(Premji, et al., 2010) 
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Post Discharge Nutrition 
The ELBW infant should continue to receive fortified 
human milk after discharge to meet their high energy 
needs and to promote growth. In cases where human 
milk is unavailable the ELBW infant should continue 
to receive a premature infant formula after discharge.  
 
The amount of human milk fortification or caloric 
density of the premature infant formula should be 
adjusted to 22kcal/ounce just prior to discharge. The 
need for additional fortification should be based on 
the ELBW infant’s disease process, weight gain, and 
history of osteopenia of prematurity. 
 
Rationale: The exact nutrient requirements for the 
ELBW infant have yet to be determined but it is clear 
that the ELBW infant continues to have a high energy 
need at time of discharge that must be met (Guilfoy, 
et. al, 2008). A systematic review of 1 RCT showed 
improvement in growth of premature infants fed 
fortified human milk upon discharge (McCormick, et 
al., 2010) In another systematic review, premature 
infants able to tolerate ad libitum feedings did not 
need a premature infant formula at discharge 
(Henderson et al., 2009). According to the AAP 
Committee on Nutrition (2004) human milk 
fortification or the use of premature infant formula 
should continue until at least 9 months of age to meet 
the additional vitamin, mineral, and caloric needs of 















(Henderson, et al., 2009; 
McCormick et al., 2010) 
 
(Guilfoy et al., 2008) 
 
(AAP Committee on 
Nutrition, 2004) 
Nutritional Assessment 
Anthropometric measurements are used to monitor 
growth in all infants and should be done on a routine 
basis to monitor growth in the ELBW infant. 
 
Weight should be measured daily with use of a bed 
scale if possible due to the critical nature of the 
ELBW infant’s illness. Weight gain should mimic the 
intrauterine growth rate of 15-20g/kg/day. 
 
 
Head Circumference should be measured weekly at 
the largest frontal occipital plan. Head circumference 
should increase by 0.9cm/week. 
 
Length should measured weekly using a recumbent 
length board to obtain the best measurement. Length 
should increase by 0.9cm/week.  
 
Rationale: Body weight is representative of total 
body mass and is reflective of changes in body 
composition to include lean tissue, fat, and the 
intracellular and extracellular fluid compartments 
(Moyer-Mileur, 2007). Head growth during infancy 
correlates well with overall growth and may indicate 
poor neurodevelopment if measurements are 
abnormal (Moyer-Mileur, 2007). Length is more 
closely associated with lean mass and is a better 






















VII Very Low Recommend (ADA Pediatric Nutrition 








Laboratory data may be used to further assess the 
nutritional status of the ELBW infant. 
Recommendations for laboratory monitoring while 
receiving parenteral nutrition are as follows: 
 
Serum glucose should be monitored as needed based 
on severity of illness and disease process. Urine 
glucose should be monitored 1-3 times a day upon 
initiation of parenteral nutrition and then as needed 
once stable. 
 
Electrolytes and acid-base balance should be 
monitored daily upon initiation of parenteral nutrition 
and continue until energy and nutrient needs are met 
and stabilized. Once requirements are stable 
electrolytes may be monitored every 1-2 weeks as 
needed. Acid-base balance may be monitored as 
needed. 
 
Calcium, phosphorus, and magnesium should be 
monitored a 2-3 times a week during the initiation of 
parenteral nutrition and then every 1-2 weeks as 
needed. 
 
Triglycerides should be monitored with every rate 
increase and then every 1-2 weeks as needed while 
receiving intralipids.  
Blood urea nitrogen (BUN) and creatinine should be 
monitored a 2-3 times a week during the initiation of 
parenteral nutrition and then every 1-2 weeks as 
needed.  
 
Serum protein levels, liver enzymes, alkaline 
phosphatase, and blood cell count should be done to 
obtain a baseline at the start of parenteral nutrition 
and then every 2-3 weeks as needed. 
 
Rationale: Monitoring laboratory data on a regular 
basis during the initiation and continued use of 
parenteral nutrition aides allows the healthcare 
provider to assess the ELBW infant’s response to 
parenteral nutrition and to identify any metabolic 
complications that may occur from the use of 
parenteral nutrition (Moyer-Mileur, 2007). 
VII Very Low Recommend (ADA Pediatric Nutrition 
Practice Group, 2009; 
Moyer-Mileur, 2007) 
Recommendations for laboratory monitoring while 
receiving enteral nutrition are as follows: 
 
A baseline evaluation of serum and urine glucose, 
electrolytes, acid-base status, BUN, creatinine, 
calcium, phosphorus, magnesium, serum protein 
levels, liver enzymes, alkaline phosphatase, and 
blood cell count should be done upon reaching full 
enteral nutrition. 
 
Once the ELBW infant is stable on full enteral 
feedings with adequate nutrient and energy intake the 
laboratory assessment of electrolytes, calcium, 
phosphorus, BUN, creatinine, serum protein levels, 
liver enzymes, blood cell count may be done every 2-
3 weeks and adjusted as needed based on clinical 
condition. 
 
Rationale: A routine monitoring schedule is not 
indicated when infants weighing less than 1,500 
grams are clinically stable and receiving adequate 
nutrition (Moyer-Mileur, 2007). The 
recommendations can be used to monitor nutritional 
status and adjusted as needed based on the clinical 
condition of the ELBW infant. 
VII Very Low Recommend (ADA Pediatric Nutrition 





DISCUSSION and IMPLICATIONS for PRACTICE 
 The aim of this CPG is to provide evidence based practice recommendations on 
the nutritional management of the ELBW infant in order to promote adequate 
extrauterine growth and prevent or at least decrease EUGR. The need for improving 
EUGR in the ELBW infant has been well documented throughout the neonatal literature 
(Carroll, Slobodzian & Steward, 2005; Clark et al., 2003; Coverston & Schwartz, 2005; 
Yu, 2005)  However, research to define the exact nutrient requirements needed to 
promote adequate extrauterine growth in the ELBW infant is limited.  
 Current nutritional management of the ELBW infant focuses on providing 
nutrition to promote weight gain that is similar to the intrauterine rate of 15-20g/kg/day, 
which has been recommended by the AAP (1985) as the gold standard for premature 
infant growth. In order to meet the AAP recommendations, ELBW infants have been fed 
diets high in fat and carbohydrates (Hay, 2006).  This type of nutritional management has 
resulted in large protein and energy deficits that lead to poor extrauterine growth and 
EUGR in the ELBW infant (Clark et al., 2003; Stephens et al., 2009). 
 Strong evidence exists for providing early aggressive nutrition to prevent the 
protein and energy deficits that occur in the ELBW infant (Ibrahim et al., 2004; Wilson, 
et al., 1997). Most of the research has focused on early administration of amino acids 
with a number of the studies being conducted in infants less than 1,500 grams. However, 
the few studies conducted in ELBW infants have consistently shown that early 
administration of amino acids prevents catabolism, promotes protein synthesis and 
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establishes a positive nitrogen balance without adverse effects (Rivera et al., 1993; 
TeBraake et al., 2005; Thureen et al., 2003; Van Goudoever et al., 1995). 
Energy requirements for the ELBW infant are still unclear and have been largely 
estimated from data obtained in healthy growing premature infants (Carr et al., 2000). 
Energy intake for the ELBW infant when receiving early amino acids has been estimated 
at 70-115kcal/kg/day (Carr et al., 2000; Hay, 2005; Leitch & Denne, 2005; Zlotkin et al., 
1981) However, providing enough energy from non-protein sources is complicated by 
hyperglycemia and glucose intolerance in the ELBW infant (Hay, 2006). Administering 
intralipids in small doses along with amino acids has been shown to improve glucose 
tolerance (Anderson, et al., 1979; Murdock et al., 1995; Rivera et al., 1993; Thureen et 
al., 2003). Although early administration of intralipids has no adverse effects, the 
evidence to support its use to promote short term growth is conflicting (Simmer & Rao, 
2009; Wilson et al., 1997).  
Early administration of amino acids and intralipids are not the only components 
that make up an early aggressive nutrition plan. Trophic feedings or MEF have been 
shown to improve feeding tolerance and later feeding advancement (Wilson et al., 1997). 
In addition, the use of MEF has been shown in two systematic reviews to have no effect 
on the incidence of NEC (Bombell & McGuire, 2009; Morgan et al., 2011a). However, 
clinicians are still withholding feedings due to the fear of NEC (Adamkin, 2005, 
Ehrenkranz, 2007). 
The exact pathogenesis of NEC is unknown but certain factors have been 
associated with its development (Neu, 2008). One of these factors is the commencement 
of enteral feedings thought to serve as a substrate for infectious organisms to multiply 
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(Lee & Jain, 2000). The use of formula has been shown to increase the incidence of NEC 
while human milk has been shown to decrease its incidence (Quigley et al., 2008). 
Despite this evidence to support exclusive human milk feeding and the recent 
advancements in providing donor human milk ELBW infants are still receiving 
premature infant formula as the feeding of choice. 
It has been recognized that exclusive human milk feeding over time will not meet 
the nutritional needs of the ELBW infant (AAP Committee on Nutrition, 2004). 
Fortification of human milk with human milk fortifiers provides the additional nutrients 
needed to promote growth and bone mineralization in premature infants (Kuschel & 
Harding, 2009). However, continuing such fortification upon discharge is controversial. 
One systematic review suggests fortified human milk promotes growth after discharge 
but the review only included 1 RCT (McCormick et al., 2010) In another systematic 
review the use of a nutrient enriched premature formula after discharge had no effect on 
growth when compared to a standard term formula, but these findings were limited to 
infants who could tolerate ad libitum feedings (Henderson et al., 2009). Yet, the AAP 
(2004) recommends human milk fortification or a premature infant formula to meet the 
additional vitamin, mineral and caloric needs of the premature infant. Furthermore, 
Guilfoy et al. (2008) found that ELBW infants continued to have high energy expenditure 
at the time of discharge despite higher caloric intake of 130kcal/kg/day. 
Determining the appropriate post-discharge nutritional regimen for the ELBW 
infant is an area needing further investigation. Especially when current evidence suggests 
additional protein supplementation of enteral feedings at 3-4g/kg/day is needed to 
promote weight gain in infants less than 2,500 grams (Premji et al., 2010). Bhatia (2005) 
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suggests that until optimal nutrition regimens are developed growth assessments need to 
be done at regular intervals with close attention to growth failure as well as growth 
excess. 
 Regular growth assessments are essential in the ELBW infant not only after 
discharge but throughout their NICU stay.  Anthropometric measurements have been 
standardized in neonatal care whereas laboratory assessment varies depending on each 
NICU and healthcare provider. This variation in practice is most likely due to a lack of 
evidence to support how often laboratory assessments should be done (Moyer-Mileur, 
2009). It is unlikely that a RCT will be done to provide strong evidence for routine 
laboratory assessments but observational or cohort studies to determine how often certain 
laboratory tests should be done would aid in the nutritional assessment of the ELBW 
infant. 
Nutritional management of the ELBW infant is not an easy task and is further 
complicated by a lack of research done solely in this population of infants. Although, 
research done in the VLBW (less than 1,500 grams) infant may be applied to the care of 
ELBW infants their extreme prematurity and organ development must still be considered 
when providing such care. Therefore, this guideline should not be used without the 
careful examination of the ELBW infant’s clinical condition and severity of illness. 
IMPLICATIONS FOR PRACTICE 
 The development of this CPG provides neonatal healthcare providers with 
evidence based recommendations on the nutritional management of the ELBW infant and 
fulfills an existing gap in neonatal practice. The recommendations in the CPG are 
centered on improving extrauterine growth and therefore preventing or at least decreasing 
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EUGR. The publication and endorsement of this guideline by NANN will help to 
standardize nutritional management of the ELBW infant across the country and 
potentially improve growth and outcomes nationwide. 
 This guideline is the first evidence based CPG addressing the nutritional 
management of the ELBW infant. A lack of research done exclusively in the ELBW 
infant population has been highlighted with the development of this CPG. Strong 
evidence exists for the early administration of amino acids, intralipids and MEF or 
trophic feedings to prevent protein and energy deficits that lead to EUGR but maintaining 
growth with enteral nutrition is less clear especially after the ELBW infant is discharged 
from the NICU. Therefore, further studies are still needed to determine the nutrient 
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